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This review covers the literature published in 2002 for marine natural products, with 579 citations 
(413 for the period January to December 2002) referring to compounds isolated from marine 
microorganisms and phytoplankton, green algae, brown algae, red algae, sponges, coelenterates, 
bryozoans, molluscs, tunicates and echinoderms.  The emphasis is on new compounds (677 for 
2002), together with their relevant biological activities, source organisms and country of origin.  
Syntheses that lead to the revision of structures or stereochemistries have been included (114), 
including any first total syntheses of a marine natural product. 
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1 Introduction 
 
In the introduction to the previous review1 in this series, we paid tribute to the late Professor D John 
Faulkner for his contributions not only to the preparation of all the prior reviews in this series, but 
also for his enormous contribution to research in marine natural products.  We are very pleased to 
be able to continue this series of reviews, especially for inclusion in this issue dedicated to John 
Faulkner. 
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Unfortunately, we now have to pay a further tribute - this time, to the late Professor Paul J 
Scheuer who died in January 2003.  Paul Scheuer has been widely regarded as the ‘grandfather’ of 
marine natural products.  There are many working in the field today who can track their academic 
genealogy back to Professor Scheuer.  Like John Faulkner, he was a true leader in the field.  His 
vision and personality have marked the last forty plus years of research into marine natural products 
and his contributions too have been of enormous impact.  Scheuer would have been cited over 150 
times in the ‘Faulkner’ review series.  The earliest reference describing his interests with marine 
natural products was his paper in 1960 on “Observations on ciguatera-type toxin in fish”.2  
Despite health problems over the past few years both Paul Scheuer and John Faulkner 
continued their vital interest in research.  An indication of their continued involvement until the 
times of their death is the inclusion in this review of four publications from Professor Scheuer 
describing 18 new compounds, and seven publications from Professor Faulkner describing 16 new 
compounds.  Over the next year much will be written about the contributions each has made, but 
one thing is certain: between them Scheuer and Faulkner set the foundations for ‘marine natural 
products’, and then were instrumental in the evolution of the general field into more niche areas 
such as marine ecology and marine pharmacology. 
This review is of the literature for 2002 and describes 677 new compounds from 257 
articles.  We show structures only for new compounds, or for previously reported compounds where 
there has been a structural revision or a newly established stereochemistry.  Previously reported 
compounds for which first syntheses or new bioactivities are described, are referenced, but 
structures are not given.   
 
2 Reviews 
 
Several reviews have dealt with particular marine-derived compounds.  The microcystins and 
nodularins are the focus of “Peptide toxins of cyanobacteria”.3  Didemnins are comprehensively 
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reviewed in “Natural products as probes of cell biology: 20 years of didemnin research”.4  “Okadaic 
acid: the archetypal serine/threonine protein phosphatase inhibitor”5 focuses on the role that okadaic 
acid has played in stimulating a broad spectrum of modern scientific research.  Dolastatins and 
related compounds are reviewed in two articles, “Symbiotic and dietary marine microalgae as a 
source of bioactive molecules”6 and “The cyanobacterial origin of potent anticancer agents 
originally isolated from sea hares”.7  A personal perspective on research programs which have been 
inspired by palytoxin has been given by Kishi.8  Callystatins are included in “The chemistry and 
biology of the leptomycin family”.9  Ecteinascidins feature in two reviews, “Ecteinascidin 743: a 
novel anticancer drug with a unique mechanism of action”10 and “Chemistry and biology of the 
tetrahydroisoquinoline antitumor antibiotics”.11  Bryostatins are reviewed in “The chemistry and 
biology of the bryostatin antitumour alkaloids”12 and “The clinical development of the 
bryostatins”.13 
A series of reviews have dealt with broad compound classes.  “Survey of briarane-type 
diterpenoids of marine origin”14 contains a compilation of 299 briarane-type metabolites.  Marine-
derived compounds are included in “Natural guanidine derivatives”,15 “Muscarine, imidazole, 
oxazole, thiazole, Amararyllidaceae and Sceletium alkaloids”,16 “Natural halogenated fatty acids: 
their analogues and derivatives”,17 “Simple indole alkaloids and those with a nonrearranged 
monoterpenoid unit”,18 “Indolizidine and quinolizidine alkaloids”,19 “Bromo- and iodo-containing 
alkaloids from marine microorganisms and sponges”,20 “Natural occurrence of boron-containing 
compounds in plants, algae and microorganisms”,21 “Sterols in marine invertebrates”,22 and 
“Structural diversity of marine oxylipins”.23  An unusual approach to looking at possible 
biosynthetic relationships is presented in “The pyridoacridine family tree: a useful scheme for 
designing synthesis and predicting undiscovered natural products”.24  Synthesis is the focus of 
“Ladder-extension in the synthesis of marine polyether toxins”.25 
Reviews of the chemistry of particular types of marine organism include “The oxylipin 
chemistry of attraction and defense in brown algae and diatoms”,26 “Bioactive compounds from 
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bryozoans”,27 “Neuropeptides in cnidarians”,28 “Toxins and bioactive compounds from 
cyanobacteria and their implications on human health”,29 “The heterocyclic natural products of 
gorgonian corals of genus Briareum exclusive of briarane-type diterpenoids”,30 “Secondary 
metabolites from marine fungi”,31 “Secondary metabolites from marine microorganisms”,32 “Pore-
forming proteins from sea anemones and the construction of immunotoxins for selective killing of 
harmful cells”,33 “A survey of the sterol composition of the marine dinoflagellates Karenia brevis, 
Karenia mikimotoi and Karlodinium micrum”,34 “The chemistry of lithistid sponge: a spectacular 
source of new metabolites”,35 and “Chemical defense of early life stages of benthic marine 
invertebrates”.36 
More general reviews have been “Drugs from the seas – current status and microbiological 
implications”,37 “Marine pharmacology in 1999: compounds with antibacterial, anticoagulant, 
antifungal, anthelmintic, anti-inflammatory, antiplatelet, antiprotozoal and antiviral activities 
affecting the cardiovascular, endocrine, immune and nervous systems, and other miscellaneous 
mechanisms of action”,38 “Australian biodiversity via its plants and marine organisms.  A high-
throughput screening approach to drug discovery”,39 and “Secondary metabolites with 
antinematodal activity”.40  While not specifically focussing on marine natural products, the article 
on “Application of a new expert system for the structure elucidation of natural products from their 
1D and 2D NMR data”41 should be of significant interest to those investigating new compounds.  
There has been a further report on the Chinese database “A marine natural product database”42 
while the Marinlit database43 continues to be updated and has again been used as the basis for the 
preparation of this present review. 
 
3 Marine microorganisms and phytoplankton 
 
Extracts of marine microorganisms, whether obtained from culture or directly from a collected 
sample, continue to yield an array of novel compounds.  A culture of Bacillus laterosporus, isolated 
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from the tissues of an unidentified tube worm from Loloata Island, Papua New Guinea, was the 
source of the novel antifungal polyketide metabolites basiliskamides A 1 and B 2 and of two new 
acyldipeptides, tupuseleiamides A 3 and B 4.44  The (S) configuration of the secondary alcohol at C-
7 in basiliskamide A 1 was determined by Ohtani’s Mosher ester analysis method,45 but the 
configuration at C-10 was not determined and is assumed to be (S) as in a known homologue.46,47  
The diagrams here for 1 and 2, showing (7S,8S,9R,10S), are corrections from those given in the 
original paper.44  The (R) configuration of the tyrosine and serine residues in tupuseleiamides A 3 
and B 4 was determined by chiral GC analysis but the configuration at C-18 was not determined.  
Basiliskamides A 1 and B 2 were both converted to the same diol by DIBAL reduction, indicating 
identical configurations in both molecules.  Basiliskamides A and B showed potent in vitro activity 
against Candida albicans while basiliskamide A 1 exhibited activity comparable to amphotericin B, 
but was at least four-fold less cytotoxic to human fibroblast cells.44  Cultured Bacillus pumilus, 
isolated from the surface of the ascidian Halocynthia aurantium from Troitza Bay in Russian 
waters, yielded a mixture of surfactin-like cyclic depsipeptides 5–9.  These lipopeptides differed 
from surfactin by substitution of the 4-valine by leucine and were isolated as two carboxy-terminal 
variants with either valine or isoleucine in the 7-position.48  The bis-catechol α-hydroxy acid 
siderophore, petrobactin 10, was isolated from the cultured oil-degrading marine bacterium 
Marinobacter hydrocarbonoclasticus.49  The cyclic hexapeptide halolitoralin A 11 and tetrapeptides 
halolitoralins B 12 and C 13 were isolated from the fermentation broth of Halobacillus litoralis, 
which had originated from a high-salt sediment from the Huanghai Sea, China.  All amino acid 
residues were established as (S) by hydrolysis and subsequent Marfey’s analysis.  The halolitoralins 
A–C 11–13 exhibited moderate antifungal activity against C. albicans, T. rubrum and four crop-
threatening fungi, in addition to moderate activity against the human gastric tumour BGC cell line.50  
The macrolide antibiotic chalcomycin B 14 was isolated from the culture broth of a Streptomyces 
sp. derived from mangrove sediment collected near Pohoiki, Hawaii.51  Chalcomycin B 14 exhibited 
activity against a variety of microorganisms and microalgae.  Cultures of Humicola grisea, a 
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filamentous fungus isolated from drift wood in New Caledonian waters, were the source of 
humicolone 15, a phenolic tetralone in acetal form that exhibited appreciable cytotoxicity towards 
KB cell lines.  The absolute configuration of humicolone 15 was established by Mosher’s method 
and molecular modelling.52  A cyclic tetrapeptide, designated JM47 16, was isolated from a marine 
Fusarium species isolated from the green alga Codium fragile subsp. atlanticum collected in 
Scottish waters and was determined to be cyclo(Ala-Ala-Aoh-Pro), where Aoh is (2S,9S)-2-amino-
8-oxo-9-hydroxydecanoic acid.53  The absolute stereochemistry of the core was determined by 
acidic hydrolysis and chiral TLC analysis of the proline residue.53  A culture of a strain of the 
mangrove fungus Eutypa sp. isolated from wood in the South China Sea yielded eutypoid A 17 
from the culture mycelium.54  Four new epipolysulfanyldioxopiperazines, leptosins M 18, M1 19, N 
20 and N1 21 were isolated from a culture of the fungus Leptosphaeria sp. originating from the 
Japanese brown alga Sargassum tortile.55  Absolute stereochemistries were determined by chemical 
analyses and transformations.  Each compound possessed significant cytotoxic activity against the 
P388 cell line while leptosin M 18 also exhibited appreciable cytotoxicity against a disease-oriented 
panel of 39 human cancer cell lines and specifically inhibited two protein kinases and 
topoisomerase II.55  A carotenoid glycosyl ester 22 was isolated from cultured cells of a Fusarium 
species isolated from the seawater surface at Tanegashima, Japan.56  Cultured Fusarium 
chlamydosporum, isolated from the Japanese marine red alga Carpopeltis affinis, was the source of 
fusaperazines A 23 and B 24, two new sulfur-containing dioxopiperazine derivatives, and two 
known compounds 25 and 26 which had been originally isolated from a fermentation of the fungus 
Tolypocladium sp.57  In the current report, the absolute configurations of 25 and 26 were determined 
by chemical transformations and the stereostructures of 23 and 24 established by comparison.58  A 
new gabosine derivative, parasitenone 27 was isolated from a culture of the fungus Aspergillus 
parasiticus from the Korean red alga Carpopeltis cornea.  The absolute configuration of 
parasitenone 27 was determined to be (4S,5S,6S) on the basis of CD data and a chemical 
transformation.59  Aspergilloxide 28, a sesterterpene epoxy-diol, was isolated from an extract of an 
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undescribed Aspergillus species from the Bahamas.  The absolute configuration was assigned by 
application of the modified Mosher method.60  The fungus Curvularia lunata, isolated from the 
marine sponge Niphates olemda from Indonesian waters, was the source of lunatin 29, shown to be 
active against S. aureus, E. coli and B. subtilis but inactive against C. albicans.61  Two new α-
pyrones, herbarin A 30 and herbarin B 31 along with a new phthalide herbaric acid 32 were isolated 
from two cultured strains of the fungus Cladosporium herbarum isolated from the sponges Aplysina 
aerophoba and Callyspongia aerizusa collected in the French Mediterranean and in Indonesian 
waters respectively.61 Herbarins A 30 and B 31 displayed activity in the brine shrimp assay.61  A 
culture of the fungus Emericella variecolor isolated from a sponge collected in the Caribbean Sea 
off Venezuela yielded varitriol 33, varioxirane 34, dihydroterrein 35 and varixanthone 36 which 
were characterised by spectroscopic methods and chemical transformations.62  Varitriol 33 
displayed increased potency toward some renal, CNS and breast cancer cell lines in the NCI’s 60-
cell line panel while varixanthone 36 displayed antimicrobial activity against a range of bacteria.62  
Macrosphelide L 37 was obtained from a strain of the fungus Periconia byssoides cultured from the 
sea hare Aplysia kurodai.63  The absolute stereostructure, along with that of macrosphelide H 38, 
previously isolated from the same fungal species,64,65 was determined by spectroscopic analyses and 
chemical transformations.  Both compounds inhibited the adhesion of human-leukemia HL-60 cells 
to human-umbilical-vein endothelial cells (HUVEC).63  The triester seco-macrosphelide E 39 was 
isolated from a strain of the fungus P. byssoides separated from the sea hare Aplysia kurodai.  The 
absolute stereostructure was elucidated by spectroscopic analyses and synthesis.66  The syntheses of 
macrosphelides H 38 and G,65 also from P. byssoides, have been published.67,68  The Japanese fish 
Halichoeres bleekeri69 was the source of a cultured strain of Streptomyces hygroscopicus from 
which halichoblelide 40, a macrolide with potent cytotoxicity against the murine P388 cell line and 
39 human cancer cell lines, was isolated.  The absolute configuration of halichoblelide 40 was 
established by spectroscopic analyses and chemical transformation.70  The source of the 14-
membered resorcylic macrolides aigialomycins A–E 41–45 was a culture of the mangrove fungus 
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Aigialus parvus.  The structures, including absolute configurations, were determined by 
spectroscopic methods, chemical conversions and X-ray analysis of a derivative of aigialomycin C 
43.  Aigialomycin D 44 displayed antimalarial activity in vitro against Plasmodium falciparum in 
addition to moderate cytotoxicity against the KB, BC-1 and Vero cell lines.71  Ten new 
sesquiterpenoids, isosativenetriol 46, drechslerines A 47 and B 48, 9-hydroxyhelminthosporol 49, 
drechslerines C–G 50–54 and sativene epoxide 55 were isolated from a culture of the fungus 
Drechslera dematioidea from the red alga Liagora viscida.  Drechslerines E 52 and G 54 exhibited 
antiplasmodial activity against two strains of P. falciparum.72  Two γ-pyrone derivatives, 
microsphaerones A 56 and B 57, were isolated from a culture of the fungus Microsphaeropsis sp. 
from the marine sponge Aplysina aerophoba collected in French waters.73  The presence of an (S)-2-
methylsuccinic acid moiety in microsphaerone A 56 was established by GC-MS analysis of a (–)-
menthylated hydrolysis product.73  Three diterpene glycosides, virescenosides O–Q 58–60 have 
been isolated from a cultured strain of Acremonium striatisporum associated with the holothurian 
Eupentacta fraudatrix.74  Virescenosides O–Q 58–60 were cytotoxic against Ehrlich carcinoma cells 
in vitro while virescenoside P 59 was also cytotoxic to developing eggs of the sea urchin 
Strongylocentrotus intermedius.74  Cultures of the marine fungus Hypoxylon oceanicum75 from 
mangrove wood from Shenzen, China, yielded the macrocyclic polyesters 61 and 62 and the linear 
polyesters 63–67.76  The absolute configurations of the polyesters were deduced from CD spectral 
studies.  Compounds 61 and 62 exhibited modest activity against the phytopathogenic fungus 
Neurospora crassa.76  The marine sponge Xestospongia exigua collected from the Bali Sea, 
Indonesia, was the source of fungal isolates of Penicillium cf. montanense.  Cultures of these 
isolates gave the xestodecalactones A–C 68–70, 10-membered macrolides with a fused 1,3-
dihydroxybenzene ring.  Xestodecalactones 69 and 70 are diastereoisomeric but only 69 was active 
against C. albicans.77  A culture of the facultative marine ascomycete Zopfiella latipes, originally 
isolated from Indian Ocean soil, was the source of zopfiellamides A 71 and B 72 which were 
moderately active against Arthrobacter citreus, B. brevis, B. subtilis, B. licheniformis, 
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Corynebacterium insidiosum, Micrococcus luteus, Mycobacterium phlei, Streptomyces sp. and 
Acinetobacter calcoaceticus.78  Halorosellins A 73 and B 74 were isolated from the culture broth of 
the marine fungus Halorosellinia oceanica of Thai origin.  In addition, 75–77 were isolated.  The 
isobenzofuran-1-one 76 exhibited moderate antimycobacterial activity.79  A culture of an 
unidentified fungus from the South China Sea yielded the cyclic tetrapeptides 78–80,80 which are 
very similar to the bacterial metabolites, the halolitoralins B 12 and C 13 (vide supra).  The 
filamentous marine fungus Keissleriella sp. isolated from a Yellow Sea sediment source gave a 
dihydronaphthalen-1(4H)-one 81 which was antifungal in vitro against C. albicans, T. rubrum and 
A. niger.81  5-Hydroxyramulosin 82 originated from the fungus Phoma tropica, isolated from the 
brown alga Fucus spiralis.  The structure was secured by an X-ray analysis.82  A Palauan collection 
of the marine cyanobacterium Lyngbya sp. was the source of the brominated glycoside macrolide, 
lyngbyaloside B 83.  The relative stereochemistry of the 12 stereocentres has been proposed on the 
basis of coupling constant and ROESY NMR data.  Lyngbyaloside B 83 exhibited weak 
cytotoxicity against KB cells.83  A related glycosidic macrolide, lyngbouilloside 84, was isolated 
from L. bouillonii collected from Papua New Guinea.  Lyngbouilloside 84 exhibited modest 
cytotoxicity to neuro-2a neuroblastoma cells.84  A Guam collection of Lyngbya sp. yielded 
apratoxin B 85 while a collection of the same species from Palau afforded apratoxin C 86.  The 
chirality of the constituent amino acids was determined as (S) by chiral HPLC analysis of the 
hydrolysis products.  Apratoxin C 86 exhibited appreciable cytotoxicity against KB and LoVo cells, 
while apratoxin B 85 and the semisynthetic (E)-dehydroapratoxin A were considerably less active.85  
Lyngbya sp. from Palau also yielded the dichlorinated thiazole hydroxy acid-containing cytotoxic 
macrolide lyngbyabellin C 87, the modified tetrapeptides lyngbyapeptins B 88 and C 89 and a 
cytotoxic N-acylpyrrolinone, palau’imide 90.86  The absolute stereochemistry of lyngbyabellin C 87 
could not be determined as only minute amounts were available but cytotoxicity to both KB and 
LoVo cell lines was noted.  One ester linkage of lyngbyabellin C was particularly prone to 
methanolysis.  Regioselective ester cleavage at C-16 caused conversion to the methyl ester  
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homohydroxydolabellin and led to the speculation that the sea hare metabolite dolabellin87 is likely 
to be an artifact rather than a natural product.  Homohydroxydolabellin had virtually identical 
activity against KB and LoVo cell lines to lyngbyabellin C 87.  The absolute stereochemistries of 
lyngbyapeptins B 88 and C 89 were found to be all (S) by chiral HPLC analysis of hydrolysis 
products and the (E) stereochemistry for the olefin in lyngbyapeptin C 89 was established by a 
ROESY NMR experiment.  The configurations of C-4 and C-15 of palau’imide 90 were deduced by 
analysis of degradation products but that at C-20 was not determined due to lack of material.  
Palau’imide was cytotoxic to KB and LoVo cells.86  The first total syntheses of the lipopeptides 
lyngbyabellin A, originally isolated from collections of L. majuscula from Guam,88 and 
lyngbyabellin B isolated from collections of Lyngbya sp. from Guam89 and Florida90 respectively, 
have been described.  The functionalised thiazole carboxylic acids were prepared by oxidative 
dehydrogenation of the corresponding thiazolidines with manganese dioxide.91  Collections of 
Lyngbya sp. from various Palauan dive sites were the source of six new β-amino acid-containing 
cyclic depsipeptides, the ulongamides A–F 91–96.  The absolute stereochemistries of the hydroxy 
acid and all α-amino acid-derived units were elucidated as (S) by chiral HPLC analysis of 
hydrolysis products.  Advanced Marfey’s analysis of the acid hydrolysates determined the 
stereochemistry of 3-amino-2-methylhexanoic acid as (2R,3R) in ulongamides A–C 91–93 and 
(2S,3R) in ulongamides D–F 94–96.  Ulongamides A–E 91–95 were weakly cytotoxic against KB 
and LoVo cells in vitro, while ulongamide F 96 was inactive.92  A Madagascan collection of L. 
majuscula was the source of further depsipeptides, the antanapeptins A–D 97–100.  Structures were 
deduced by 2D NMR and mass spectral analysis.93  A 36-membered macrolactone 
(25S,27S,29S,33S)-caylobolide A 101 was isolated from L. majuscula from the Bahamas.  The 
relative stereochemistry of the 1,3,5-triol was determined using Kishi’s Universal NMR database 
while the absolute stereochemistry at C-25, C-27, C-29 and C-33 was determined by Mosher’s 
analysis.  Caylobolide A 101 displayed cytotoxicity against human colon tumor cells (HCT-116) in 
vitro.94  Hectochlorin 102 was isolated from L. majuscula collected from Hector Bay, Jamaica, and 
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Boca del Drago Beach, Panama.  The absolute stereochemistry of 102 was determined as 
(2S,3S,14S,22S) by X-ray analysis.  Hectochlorin 102, a potent stimulator of actin polymerisation, 
shows a unique profile of cytotoxicity by the COMPARE algorithm in the NCI panel and is 
strongly inhibitory towards C. albicans.95  A total synthesis of hectochlorin 102 has now been 
accomplished.96  A mixed assemblage of L. majuscula and a Schizothrix sp. from Fijian waters 
yielded the cytotoxic disulfide dimer somocystinamide A 103.  The absolute stereochemistry was 
established as (2R,2'R) by HPLC analysis of hydrolysis products.97  A collection of L. confervoides 
from Saipan in the Commonwealth of the Northern Mariana Islands was the source of a cytotoxic 
cyclic depsipeptide, obyanamide 104.  The absolute stereochemistry was determined by chiral 
chromatography of hydrolysis products and comparison with authentic and synthetic standards.  
Obyanamide 104 was cytotoxic to KB cells.98  An antifungal cyclododecapeptide, lobocyclamide B 
105 has been isolated from a benthic mat of L. confervoides from the Bahamas.  The absolute 
stereochemistry of 105 was established by a combination of chiral HPLC and Marfey’s methods.  
Lobocyclamide B 105 displays antifungal activity against fluconazole-resistant C. albicans.99  
Maculalactone M 106, a benzofuranone derivative, was isolated from the epilithic encrusting 
cyanobacterium Kyrtuthrix maculans collected in Hong Kong.  The planar structure was established 
by spectral analysis but an attempt to determine the absolute stereochemistry by CD spectroscopy 
was unsuccessful.100  A new dolastatin 10101 analogue, symplostatin 3 107, has been isolated from a 
tumour-selective extract of an Hawaiian collection of Symploca sp. VP452 which taxonomically 
appears to be S. hydnoides.  The absolute stereochemistry of 107 was established by chiral HPLC of 
acid hydrolysis products.  Symplostatin 3 107 only differs from dolastatin 10 in the C-terminal unit, 
where the dolaphenine unit is substituted by a 3-phenyllactic acid residue.  Symplostatin 3 also 
displays strong in vitro cytotoxicity towards a range of human tumour cell lines and disrupts 
microtubules but at a higher concentration than dolastatin 10.102  A cytotoxic peptide ester, 
malevamide D 108, closely related to isodolastatin H,103 was isolated from an Hawaiian collection 
of S. hydnoides.  Partial stereochemical assignments were made by chiral HPLC analysis of 
 13 
hydrolysates.  Malevamide D 108 displayed toxicity against P388, A-549, HT-29 and MEL-28 cell 
lines in the sub-nanomolar range.104  A Palauan collection of Symploca sp. was the source of the 
acyclic peptide tasiamide 109.  The absolute stereochemistry of 109 was established by chiral 
HPLC of degradation products.  Tasiamide 109 was cytotoxic against KB and LoVo cells.105  A 
laboratory culture of a Phormidium sp. from Sulawesi, Indonesia yielded phormidolide 110, a 
bromine-containing macrolide.  The absolute stereochemistry of the 11 stereocentres was 
determined on a bis-acetonide derivative using the variable temperature Mosher ester method.  
Phormidolide 110 was a potent brine shrimp toxin.106  A new cytotoxic polyether, gymnocin-A 111 
has been isolated from a culture of the red tide dinoflagellate Gymnodinium mikimotoi from 
Japanese waters.  The structure, which consists of 14 contiguous ether rings and a 2-methyl-2-
butenal sidechain, was determined by NMR and mass spectral analysis while the absolute 
stereochemistry of 111 was elucidated by the modified Mosher method.  Gymnocin-A 111 was 
cytotoxic in a cell-based assay but only weakly toxic to fish.107  The first total synthesis of the 
polycyclic ether toxin (–)-gambierol, isolated from cultured cells of the ciguatera-causative 
dinoflagellate Gambierdiscus toxicus,108 has been achieved.109,110  The synthesis features a Stille 
coupling for the stereoselective construction of the triene sidechain.110  The absolute 
stereochemistry at eight chiral centres in amphidinolide E 112, a cytotoxic 19-membered macrolide 
isolated from the marine dinoflagellate Amphidinium sp.,111 has been determined as 
(2R,7R,8R,13S,16S,17R,18R,19R) by NMR spectroscopic data analysis, modified Mosher’s method 
and the exciton chirality method.112  Meanwhile, six new macrolides, amphidinolides H2–H5 113–
116, G2 117 and G3 118 were isolated from the dinoflagellate Amphidinium sp. obtained from an 
Okinawan acoel flatworm Amphiscolops sp.113  The absolute stereochemistries of compounds 113–
117 were determined from coupling constant data, distance geometry calculations and chemical 
means, while that of amphidinolide G3 118 was established by comparison of NMR data with those 
of amphidinolide G.114  Compounds 113–117, in addition to amphidinolides G–H, 114 B,115 D116 and 
five derivatives of amphidinolide H, exhibited varying levels of cytotoxicity against murine L1210 
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cells and human epidermoid carcinoma KB cells.113  A further cytotoxic 12-membered macrolide, 
amphidinolide W 14160/1, has also been isolated from an Amphidinium sp. from the flatworm 
Amphiscolops sp.117  Spectroscopic means, including analysis of 13C-13C INADEQUATE 
correlations for a 13C-enriched sample, established the structure, while the absolute stereochemistry 
of 14160/1 was assigned by J-based configuration analysis and the modified Mosher method.  
Amphidinolide W 119 is the first macrolide without an exomethylene unit among all 
amphidinolides obtained to date.118  Three groups more or less simultaneously succeeded in 
achieving total syntheses of the originally proposed structure of amphidinolide A,119 via a ring-
closing metathesis,120 ruthenium-catalysed alkene-alkyne coupling121 or employing extensive use of 
inter-and intramolecular Stille reactions.122  It was concluded that the structure of amphidinolide A 
needed revision.  A total synthesis of amphidinolide T4123 has been accomplished.124  A digalactosyl 
diacylglycerol 120 was isolated from a culture of the Japanese marine dinoflagellate Heterocapsa 
circularisquama.  Compound 120 exhibits cytolytic activity towards oyster heart cells.125  The first 
stereoselective synthesis of the cytotoxic peptide aspergillamide B from an Aspergillus sp.126 has 
been reported127 as well as the first total synthesis of somamide A, a 19-membered macrocyclic 
depsipeptide isolated from assemblages of the cyanobacteria L. majuscula and Schizothrix sp.128  
The anti-inflammatory and anti-proliferative properties of scytonemin, an extracellular sheath 
pigment originally isolated from the cyanobacterium Stigonema sp.,129 have been reported.130,131  
Goniodomin A, an antifungal polyether macrolide from the dinoflagellate Goniodoma 
pseudogoniaulax132 has been shown to inhibit angiogenesis by inhibition of endothelial cell 
migration and basic fibroblast growth factor (bFGF) induced tube formation and is active in vivo.133 
 
4 Green algae 
 
Relatively few compounds have been reported from green algae recently.  From the Cuban green 
alga Cymopolia barbata six new prenylated bromohydroquinones were isolated 121–126.134  The 
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NMR data for five known but related cymopol compounds were also assigned, as literature 
data135,136 were either incomplete or unassigned.134  The green alga Codium iyengarii from the 
Karachi coast of the Arabian Sea was the source of a new steroid, iyengadione 127 and two new 
steroidal glycosides, iyengarosides A 128 and B 129.  Iyengaroside-A 128 displayed moderate 
activity against a range of bacteria.137  Two novel carotenoid C14:1 trans-Δ2 esters, siphonaxanthin 
C14:1 trans-Δ2 ester 130 and 6'-hydroxy siphonaxanthin C14:1 trans-Δ2 ester 131 were isolated 
from the green alga Pterosperma cristatum collected in Japanese waters.138  An inseparable mixture 
of nitrogenous glycerolipids 132–134 was isolated from the green alga Ulva fasciata collected from 
the Indian Coast.  133 was the major component of the mixture.139  Some glycoglycerolipids from 
the green alga Ulvella lens have been identified as chemical inducers to settlement and 
metamorphosis of planktonic larvae of the sea urchin Strongylocentrotus intermedius.140 
 
5 Brown algae 
 
Terpenoids and steroids dominate the compounds reported from brown algae.  In the course of 
examination of the sterol composition of the brown alga Cystoseira crinita collected in the 
Mediterranean off Turkey, a new sterol 24-norchola-5,22-dien-3β-ol, was identified by GC-MS 
analysis.141  Stypolactone 135, a diterpenoid of mixed biogenesis has been isolated from the brown 
alga Stypopodium zonale.  The structure and relative stereochemistry were determined from 
spectroscopic evidence and biogenetic considerations.  Stypolactone 135 displayed weak 
cytotoxicity in vitro against the A-549 and H-116 cell lines.142  Two diterpenoids with a novel 
skeleton, dictyterpenoids A 136 and B 137, were isolated from the brown alga Dilophus okamurae 
collected from the Japan Sea Coast and displayed antifeedant activity against young abalone.143   S. 
carpophyllum from the South China Sea was the source of two new bioactive sterols 138 and 139.  
These sterols induced morphological abnormality in the plant pathogenic fungus Pyricularia oryzae 
and 138 also exhibited cytotoxic activity against several cultured cancer cell lines.144  S. polycystum 
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collected in the North China Sea yielded a new sterol, stigmast-5,23,25-triene 140.145  The absolute 
configuration of the secondary alcohol in fucoxanthin 141, isolated in this case from the brown alga 
Turbinaria triquatra but otherwise ubiquitous in brown algae,146 was determined by the Mosher 
method.  The T. triquatra extract displayed activity against NINH3T3 fibroblast and KA3IT murine 
cancer cell lines.147  Three loliolide derivatives, 142–144 have been isolated from the brown alga 
Undaria pinnatifida from Japanese waters.  Containing a hemiacetal group, 142 is a unique loliolide 
derivative.  The relative stereochemistry of 142 was determined by NOE measurements while 143 
and 144 were determined to be diastereomers.148  The tropical brown alga Stypopodium zonale 
collected off the coast of Tenerife was the source of three terpenoids 145–147.  Structures and 
relative stereochemistries were determined from the derived methyl esters.  The methyl ester of 147 
exhibited in vitro cytotoxic activity against HT-29 H-116 and A-549.149  Two shikimate derivatives 
148 and 149 were isolated from the brown alga Spatoglossum variabile collected from the coast off 
Karachi.150  Total syntheses of sporochnols B and C, fish feeding deterrents originally isolated from 
the brown alga Sporochnus bolleanus,151 have been reported, using the C-H insertion reaction of 
alkylidenecarbene as the key step.152  Total syntheses of dictyochromenol 150 from the brown alga 
Dictyopteris undulata from Japan153 and the (Z)-stereoisomer have been reported and it was 
established that the natural enantiomer has an (R) configuration.154  A total synthesis of yahazunol, 
originally isolated from the brown alga Dictyopteris undulata,155 has been achieved, starting from 
(+)-albicanic acid.156 
 
6 Red algae 
 
As for the brown algae, terpenoids and steroids are the dominant metabolite classes reported from 
red algae.  A monoterpene, prefuroplocamioid 151, has been isolated from a Chilean sample of 
Plocamium cartilagineum.  The (Z)-stereochemistries of the double bonds along with the C-6 
relative stereochemistry were determined from NMR analyses but instability problems prevented 
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assignment of absolute stereochemistry.157  This P. cartilagineum was also the source of the 
plocamenols A–C 152–154, linear polyhalohydroxylated monoterpenes,158 and three other 
halogenated monoterpenes 155–157.159  The structures and relative stereochemistries of these 
compounds were elucidated by spectroscopic means and led to assignment of the relative 
stereochemistry at C-7 as (S*) for furoplocamioids A-C, also from P. cartilagineum.160  P. 
cartilagineum  was the source of yet another new halogenated monterpene 158.161  The antifeedant 
effects of a range of halogenated monoterpenes, originally isolated from P.  cartilagineum160, 162–166 
and Pantoneura plocamioides,167 were tested against several divergent insect species including the 
Colorado potato beetle Lepinotarsa decemlineata, the aphids Myzus persicae and Ropalosiphum 
padi, and Spodoptera frugiperda-derived Sf9 cells.161   Two C15 acetogenins containing a terminal 
bromoallene moiety, itomanallenes A 159 and B 160, and a brominated sesquiterpene itomanol 161, 
have been isolated from Laurenica intricata from Okinawa.168  Another Okinawan red alga, L. 
yonaguniensi, was the source of neoirietetraol 162, a brominated diterpene based on the rare 
neoirieane skeleton.  Also isolated was a chlorinated C15 acetogenin, (3Z)-laurenyne 163.  The 
relative stereochemistry of 162 was determined from spectral data but an attempt to determine the 
absolute configuration was unsuccessful.  Both neoirietetraol 162 and (3Z)-laurenyne 163 were 
toxic to brine shrimp and 162 was active against the marine bacteria Alcaligenes aquamarinus and 
E. coli.169  Three halogenated rearranged sesquiterpenes 164–166 containing the brasilane skeleton 
and a 1,6-epoxy moiety have been isolated from L. obtusa collected off Symi Island in the Aegean 
Sea, Greece.  The structures and relative stereochemistries were established by spectral data 
analyses and molecular modelling.170  Bromocyclococanol 167, a sesquiterpene possessing a novel 
skeleton, was isolated from L. obtusa from Cayo Coco, Cuba.  The structure and stereochemistry 
were established from spectroscopic data and biogenetic considerations.171  The 5-acetate derivative 
168 of prepacifenol was isolated from both L. filiformis and the sea hare predator Aplysia parvula 
collected from Taroona, Tasmania.  Also isolated was the known prepacifenol, originally found in a 
Laurencia sp. seaweed.172  An X-ray analysis was reported for 168 and the NMR spectra of 
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prepacifenol were fully assigned for the first time.  Both compounds exhibited moderate activity in 
the brine shrimp bioassay.173  The first 6,8-cycloeudesmane sesquiterpene of marine origin 169, has 
been isolated from L. microcladia from the Baia di Calenzana, Elba Island.174  L. obtusa, collected 
from off Symi Island in the Aegean Sea, Greece was the source of four C15 acetogenins, 13-
epilaurencienyne (3Z) 170, 13-epipinnatifidenyne (3E) 171 and two diacetoxypentadec-3-en-1-yne 
derivatives 172–173.  170 and 173 exhibited strong toxicity to ants with considerable knockdown 
effect on the first day, while compounds 171 and 172 exhibited gradual toxicity that escalated at the 
fourth day with >70% mortality.175  The structures and relative stereochemistries of four undecane-
3-one sequiterpenes 174–177 and perforenone D 178 have been reported from L. obtusa collected at 
Milos Island in the Aegean Sea, Greece.  The relative stereochemistry of the known compound 
perforatone 179 was also revised.176  Two sesquiterpenes with an oxacyclic chamigrene skeleton, 
oxachamigrene 180 and 5-acetoxyoxachamigrene 181, have been isolated from L. obtusa from 
Cayo Coco, Cuba.177  L. viridis from Tenerife, Canary Islands was the source of three polyethers, 
clavidol 182, 3-epi-dehydrothyrsiferol 183 and lactodehydrothyrsiferol 184.  The relative 
stereochemistries were proposed on the basis of ROESY and NOEDIFF data and biogenetic 
considerations.178  The Indonesian red alga Vidalia sp. was the source of the phenolic metabolite 
vidalenolone 185,179 while a new 3,6-diketosteroid 186 was isolated from the red alga Hypnea 
musciformis collected on the Atlantic Coast of Morocco.  186 exhibited anti-elastase activity 
against porcine pancreas elastase (PPE).  Two novel steroids 187 and 188 were also isolated as an 
inseparable mixture.180  A sulfoglycolipidic fraction from the red microalga Porphyridium 
cruentum, shown to contain large amounts of palmitic acid, arachidonic acid and eicosapentaenoic 
acid, strongly inhibited production of the superoxide anion and growth of DLD-1, MCF-7, PC-3 
and M4 Beu cell lines.181   
Several syntheses of red algal metabolites were reported in 2002.  2,3,6-Tribromo-1-
methylindole, originally isolated from L. brongniartii182 has been synthesised from 2,3-dibromo-1-
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methylindole,183 and the first asymmetric total synthesis of (+)-laurenyne, a metabolite of Laurencia 
obtusa,184 has been achieved.185   
 
7 Sponges 
 
The phylum Porifera (sponges) continues to be a rich source of novel secondary metabolites, with a 
diversity of biological activities that continue to inspire the efforts of synthetic organic chemists.  A 
pair of ceramides with variable alkyl chain lengths 189 and 190 were isolated from Clathria 
fasciculata collected in southern China.186  Pachastrissamine 191, a sphingosine derivative, was 
reported from the Okinawan sponge Pachastrissa sp. and the absolute stereochemistry determined 
from analysis of the MTPA amides.187  The relative and absolute stereochemistry of the 
immunosuppressive sphingolipid, plakoside A 192, isolated from the Caribbean sponge Plakortis 
simplex,188 was finally determined by degradation and derivatisation.189,190  The cyclopropyl-
containing side chains were cleaved off as carboxylic acids from the natural product.  These acids 
were synthesised with known absolute stereochemistry and derivatives with (1S,2S)- and (1R,2R)-2-
(2,3-anthracenedicarboximido)-cyclohexanol were prepared and compared by HPLC.  Previous 
syntheses of plakoside with the correct,191 and incorrect192 relative stereochemistry had resulted in 
compounds with the same optical rotation.  The methyl ester of 5,9,23-triacontatrienoic acid 193, 
isolated from Chondrilla nucula collected from the French Mediterranean coast, was found to 
inhibit elastase.193  Two further new cytotoxic cyclitol derivatives, sarcotride B 194 and C 195 were 
isolated from a Korean Sarcotragus sp.194  The isocrasserides 196–206 were isolated from the 
Caribbean sponge Plakortis simplex.195  The authors report that the isocrasserides 196–206 and the 
related, previously described crasserides,196 were found in all sponges examined from a wide variety 
of genera within the phylum and propose that they are a characteristic, distinguishing metabolite of 
the phylum Porifera.  The antimicrobial glycolipid caminoside A 207, isolated from Dominican 
specimens of Caminus sphaeroconia, was found to be a potent inhibitor of the bacterial type III 
secretion system.197  The lembehynes B 208 and C 209, isolated from an Indonesian species of 
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Haliclona, were found to possess neuritogenic activity against neuroblastoma cells.198  
Strongylodiol A, originally isolated from an Okinawan Strongylophora species,199 has been 
synthesised confirming the (R) stereochemistry.200  Japanese specimens of Callyspongia truncata 
yielded the α-glucosidase inhibitor callyspongynic acid 210201 while corticatic acids D 211 and E 
212 along with the previously reported corticatic acid A,202 were isolated from a Japanese Petrosia 
corticata and found to be geranylgeranyltransferase type I inhibitors.203  A cytotoxic fatty acid, 
(5Z,9Z)-22-methyl-5,9-tetracosadienoic acid 213 was isolated from Geodinella robusta collected 
from the Sea of Okhotsk, Russia.204  A series of polymethoxydienes 214–218, similar to the alkenes 
isolated from the cyanophyte Tolypothrix conglutinata,205 were isolated from a Philippine specimen 
of Myriastra clavosa, and found to be moderately cytotoxic.206  Plakortis nigra, collected from a 
depth of 115 m in Palau, was found to contain epiplakinic acids G 219 and H 220 and the γ-lactones 
221 and 222 along with several β-carbolines (vide infra).  All compounds were found to inhibit the 
growth of HCT-116 cells.207  A peroxylactone, originally isolated from a Plakinastrella species,208 
has been synthesised as a racemic mixture.209  Two new 1,2-dioxolane peroxide acids 223 and 224, 
isolated from P. onkodes collected in Florida, possessed moderate antifungal activity.210  A 1,2-
dioxane peroxide acid 225, also with moderate antifungal activity, was isolated from a Jamaican 
specimen of Plakortis halichondrioides.210  The relative and absolute stereochemistry of the cyclic 
peroxide 226, originally isolated from P. angulospiculatus,211 has been proposed by comparison to 
the optical rotation and NMR spectral data of synthesised diastereomers.212  Seven methyl esters, 
plakortethers A–G 227–233 with selective toxicity towards murine macrophage cells (RAW 264-7), 
were obtained from a Bahaman specimen of P. simplex.213  Plakortone D 234, originally isolated 
from P. halichondrioides,214 has been synthesised thereby establishing the relative stereochemistry 
of C-10 and its absolute configuration as illustrated.215  The plakortides named I and J, recently 
isolated from the Jamaican sponge Plakortis sp.,216 have been renamed plakortides M and N as the 
names plakortide I and J had been used previously for related metabolites isolated from P. simplex 
collected in the Bahamas.217  Theonella cf. swinhoei from Indonesia was found to contain the 
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bitungolides A–F 235–240 which were shown to weakly inhibit dual-specificity phosphatase.218  
Subereatensin 241 was isolated from a Thailand specimen of Suberea aff. praetensa.219  An 
Okinawan collection of Terpios hoshinota contained the cytotoxic alcohol terpiodiene 242.220  The 
symbiotic complex of the sponge Haliclona cymaeformis and the red alga Ceratodictyon 
spongiosum collected in the Philippines was found to contain p-sulfooxyphenylpyruvic acid 243 
and its phenol congener 244.221  Five new cytotoxic discodermolide analogues 245–249 were 
isolated from several different Discodermia sp. specimens collected in the Bahamas.222  The highly 
cytotoxic metabolite swinhoeiamide A 250, related to calyculinamide A, was obtained from 
Theonella swinhoei collected in Papua New Guinea.223  The same compound with similar optical 
activity was isolated from an Australian collection of Luffariella geometrica and named geometricin 
A.224  Another calyculin A congener, hemicalyculin A 251 with potent cytotoxicity, has been 
obtained by bioassay-guided fractionation of Japanese specimens of Discodermia calyx, the original 
organism from which calyculin was isolated.225  An enantioselective synthesis of bengamide Z, 
originally isolated from a Jaspis sp.,226 has been reported.227,228  Two potently cytotoxic amides, 
theopederins K 252 and L 253, were obtained from a Discodermia species collected from 
Honduras.229   
Sponges continue to be a rich source of novel and biologically active peptides.  The inhibitor 
of factor VIIa and thrombin, dysinosin A 254, was isolated from a new genus of dictyoceratid 
sponge of the family Dysideidae from Australia.230  The structure of dysinosin A has been 
confirmed by stereoselective synthesis.231  The cyclic tripeptide renieramide 255, which was 
isolated from a new species of Reniera collected in Vanuatu, showed immunomodulatory 
activity.232  Interestingly, the structure of 255 proved to be identical to a patented synthetic analogue 
of the microbial product OF4949.233  A Northern Australian collection of Leucetta microraphis 
yielded the cytotoxic heptapeptide leucamide A 256.234  Cyclotheonamides E2 and E3, originally 
isolated from a Theonella species,235 have been synthesised.236,237  Two new cyclotheonamides E4 
257 and E5 258 were obtained from an Ircinia sp. from Japan and were found to be potent tryptase 
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inhibitors.238  The trans, trans rotamer of ceratospongamide has been synthesised along with the 
previously reported cis, cis isomer.239,240  Both forms of ceratospongamide were originally isolated 
from the symbiotic complex of Sigmadocia symbiotica and its host red alga Ceratodictyon 
spongiosum.241  The two rotamers were remarkably stable at temperatures up to 95 °C, but could be 
interconverted at 175 °C in DMSO.  The trans, trans rotamer was found to be a potent inhibitor of 
the expression of secreted phospholipase A2 (sPLA2) while the cis, cis form was inactive.241  
Similarly, two distinct conformers of the previously reported peptide phakellistatin 2 259 were 
isolated and characterised from the Fijian specimen of Stylotella aurantum.242  The less polar 
conformer was found to contain an intramolecular hydrogen bond.  Phakellistatin 2 was originally 
isolated from Phakellia carteri and reported to be potently cytotoxic.243  A subsequent reisolation 
and a total synthesis failed to reproduce the biological activity.  The less polar conformer isolated 
from Stylotella was found to have a similar activity to that originally reported, and was found to 
lose activity at room temperature on standing for several weeks.242  Isolated from the same sponge 
was the weakly cytotoxic octapeptide axinellin C 260.244  The structures proposed for halipeptins A 
261 and B 262, originally isolated from a Haliclona species from Vanuatu,245 have been revised.246  
The molecular formulae have been revised to include sulfur, replacing the proposed oxazetidine 
ring with a thiazoline moiety 263 and 264.  A new compound, halipeptin C 265 was obtained from 
the same sponge.246  A Palauan specimen of the genus Haliclona was found to contain the new 
haliclonamides C–E 266–268 which were found to repel the settlement of Mytilus edulis adults.247  
Two depsipeptides with nematocidal activity, phoriospongins A 269 and B 270, were isolated from 
both a Phoriospongia species and Callyspongia bilamellata from southern Australia.248  Callipeltins 
D 271 and E 272 were isolated from a Latrunculia species collected from Vanuatu.249  The 
determination of the presence of (R)-allo-threonine and (R)-alanine in their structures by use of 
Marfey’s reagent led to the re-examination of the stereochemistry of callipeltin A 273, originally 
isolated from a Callipelta species.250  The stereochemistry has been revised as illustrated.  A 
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Japanese collection of Theonella swinhoei was found to contain an antibacterial depsipeptide 
nagahamide A 274.251   
Sponge derived macrolides have proven to be of considerable interest to both synthetic and 
natural product research groups.  Callipeltoside A 275, originally isolated from a Lithistid sponge of 
the genus Callipelta,252 has been synthesised stereoselectively independently by two groups, 
establishing the relative and absolute stereochemistry of the chlorocyclopropyl side chain.253–255  The 
structure of lasonolide A, isolated from a Caribbean Forcepia species,256 has been revised to 276 by 
enantioselective synthesis of its antipode.257,258  (+)-Dactylolide 277, isolated from a Dactylospongia 
species,259 has been synthesised, establishing both the relative stereochemistry of the 
acyloxymethine and overall absolute stereochemistry.260,261  Interestingly, it appears to be a pseudo-
enantiomer of the closely related sponge metabolite (–)-zampanolide.262  Clavosides A 278 and B 
279 were isolated from the Philippine sponge Myriastra clavosa.263  The same compounds were 
described independently from M. clavosa, along with clavosides C 280 and D 281.264  A new 
mycalolide, 30,32-dihydroxymycalolide 282, with potent cytotoxicity, was obtained from Mycale 
izuensis from Japan.265  A macrolide lactam, poecillastrin A 283, related in structure to the 
chondropsins,266 was isolated from a Bahamas collection of a deep water Poecillastra species.267  
Poecillastrin A was found to have cytotoxicity and antiproliferative properties similar to those of the 
chondropsins.  Two brominated dibenzo-p-dioxins, spongiadioxin C 284 and the methyl ether 285, 
found to inhibit the division of fertilised sea urchin eggs, were isolated from an Australian 
collection of Dysidea dendyi.268  The moderately cytotoxic thioester irciniamine 286 was isolated 
from an Ircinia species collected in Japan.269  The previously reported motuporins A–C 287–289270 
along with the new congeners D–F 290–292 were found to inhibit the invasion of breast carcinoma 
cells into new tissues.  These compounds were isolated from Xestospongia exigua collected in 
Papua New Guinea along with an unresolved mixture of three isomers 293.271  Xestamine D, 
originally isolated from Calyx podatypa,272 has been synthesised employing a palladium coupling 
strategy.273  The syntheses of hachijodines F and G, originally isolated from an Amphimedon 
 24 
species,274 have also been reported.275  The structure 294, originally proposed for pyrinodemin A 
isolated from an Amphimedon species,276 was synthesised independently by two groups but did not 
have spectral characteristics identical to the natural compound.277,278  The alternative structure 295 
was proposed and synthesised by both groups.  Recently, a third structure 296 has been synthesised 
which matches the spectral data reported for the natural compound more closely.  The researchers 
note “that it would be hasty to conclude that 296 is the correct structure of natural pyrinodemin 
A”.279  A Halichondria species collected from Eritrea was found to contain the bispiperidine 
alkaloid halichondramine 297.280  The relative stereochemistry of each piperidine ring was 
determined but their stereochemical relationship remains unresolved due to severe spectral overlap.  
Two novel N-oxide containing alkaloids araguspongines K 298 and L 299 were isolated from Saudi 
Arabian specimens of Xestospongia exigua.281  A Western Australian Xestospongia species yielded 
(7S)-hydroxyxestospongin A 300; its absolute stereochemistry, and that of the previously reported282 
(+)-xestospongin D 301, was determined by X-ray analysis.283  Three novel manzamine type 
alkaloids, ent-12,34-oxamanzamines E 302, F 303 and 12,34-oxamanzamine A 304 were isolated 
from three closely related species of an undescribed genus of the family Petrosiidae (Order 
Haplosclerida) from Indonesia.284  An intramolecular Stille/Diels-Alder reaction has been employed 
in the enantioselective synthesis of ircinal.285  The bromoindole 305, isolated from a South 
Australian Hymeniacidon species was found to have nematocidal activity.286  A Micronesian sponge 
belonging to the order Haplosclerida, and probably representing a new genus, contained a cathepsin 
inhibitor haploscleridamine 306.287  N-3'-Ethylaplysinopsin 307, isolated from the Jamaican sponge 
Smenospongia aurea, has a high affinity for the human serotonin 5-HT2 receptor.288  A 
diketopiperazine 308, isolated from Geodia barretti collected at 300 m from Norwegian waters, was 
found to have spectral data identical to that of barettin previously isolated from the same sponge 
and originally assigned as structure 309.290  A subsequent synthesis of 309 disproved this structure 
for barettin.291  A Smenospongia species from Queensland, Australia, yielded the bisindole 310.292  
Hyrtios reticulata from Indonesia was found to contain 1,6-dihydroxy-1,2,3,4-tetrahydro-β-
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carboline 311, while Hyrtios erectus, also from Indonesia, yielded hyrtiosulawesine 312 and 5-
hydroxy-3-(2-hydroxyethyl)-indole 313.293  Piperazine-based bisindole metabolites have received 
considerable synthetic attention.  Hamacanthin B 314 from a deep water Hamacantha species294 has 
been synthesised and the absolute stereochemistry determined as (S).295  The cis and trans 
diastereomers of 6'-debromo-3,4-dihydrohamacanthin A, originally isolated from Rhaphisia 
lacazei,296 have been synthesised as a diastereoisomeric and a racemic mixture; similarly, 6'-
debromo-cis-3,4-dihydrohamacanthin B was also prepared.297  The trans isomer of 
dihydrohamacanthin A from the same sponge was also synthesised along with the cis isomer of 
dragmacidin C.298  Dragmacidin D, isolated from a Spongosorites species,299,300 has been synthesised 
as a racemic mixture.301  The plakortamines A–D 315–318 were isolated from the same deepwater 
Plakortis nigra specimens that yielded the epiplakinic acids (vide supra).207  A series of sulfamate 
indoles 319–322 and an indolocarbazole 323 were isolated from a New Zealand Ancorina 
species.302  Makaluvamine O 324 was isolated from the same Jamaican collection of Smenospongia 
aurea that was found to contain N-3'-ethylaplysinopsin 307.288  The Indopacific sponge Zyzzya 
fuliginosa yielded batzelline D 325 and isobatzelline E 326 which was found to inhibit the cell 
fusion of HIV-1.303  A synthesis of discorhabdin A, originally isolated from a Latrunculia species,304 
has been reported.305  Thorectandamine 327, a β-carboline alkaloid with weak cytotoxicity, was 
obtained from a Palauan Thorectandra species.306  Four new cytotoxic bisannulated acridines 5-
methoxyneoamphimedine 328, neoamphimedine Y 329, neoamphimedine Z 330, and alpkinidine 
331 were isolated from Xestospongia cf. exigua (328) and X. cf. carbonaria (328–331).307  Slagenins 
B and C, originally isolated from Agelas nakamurai,308 were synthesised with the correct absolute 
stereochemistry.309  The stereochemistry of slagenin A 332, also from Agelas nakamurai, was 
established by an independent stereoselective approach that also produced slagenins B and C.310  
Racemic syntheses of both dibromophakellstatin from Phakellia mauritiana311 and 
dibromophakellin from Acanthella carteri312 have been achieved.313  An Agelas species collected in 
the Bahamas was found to contain monobromoisophakellin 333 which along with related 
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bromopyrroles was found to inhibit feeding by the reef fish Thalassoma bifasciatum.314  (E)-
Debromoaxinohydantoin isolated from a Hymeniacidon species,315 and (Z)- 
debromoaxinohydantoin, also known as spongiacidin C, isolated from Stylotella aurantium316 and a 
Hymeniacidon species,317 have both been synthesised.318  Stereoselective syntheses of agelastatins A 
and B from Agelas dendromorpha319 have been reported.320,321  The cytotoxic imidazole alkaloids 
naamine C from Leucetta chagosensis,322 and pyronaamidine from a Leucetta species323 have been 
synthesised.324  Two related imidazole alkaloids 334 and 335 have been isolated from an Australian 
specimen of L. chagosensis while a third compound 336 was obtained from a Fijian specimen of a 
closely related sponge.325  Bromosceptrin 337, a dimeric pyrrole alkaloid, was obtained from a 
Florida Keys specimen of Agelas conifera.326  Crambescidin 359 338, isolated from Monanchora 
arbuscula,327 has been synthesised stereoselectively establishing the absolute stereochemistry.328  A 
Verongid sponge of the family Aplysinellidae collected in Okinawa yielded nakirodin A 339 and 
the absolute stereochemistry was established by the hydrolytic release of N,N,N-trimethyl-(R)-
homoserine.329  Psammaplins K 340 and L 341 were obtained from the Fijian sponge Aplysinella 
rhax.330  Psammaplin A, previously described from a Psammaplysilla species,331 was found to be a 
chitinase inhibitor.  A Druinella species, also from Fiji, was found to contain purealidin S 342 and 
purpuramine J 343, which were both moderately cytotoxic.332  The endemic Brazilian sponge 
Aplysina caissara yielded caissarines A 344 and B 345.333  Bastadin 21 346 was isolated from 
Ianthella quadrangulata from Queensland, Australia.334  The formamide-containing seco-xanthine 
hymeniacidin 347 was obtained from the same specimen of an Australian Hymeniacidon species 
from which bromoindole 305 was reported (vide supra).286  Pseudoanchynazines A–C 348–350, 
containing a methylcarbamate moiety, were isolated from an Argentinian Clathria species.335  
Stereoselective syntheses of 18-methoxyavarone isolated from Dysidea cinerea336 and D. avara,337 
and 19-methoxyavarone from a Dysidea species338 and D. avara337 have been accomplished.339  
Aureol, originally isolated from Smenospongia aurea,340 has been synthesised with the correct 
absolute stereochemistry via a rearrangement of (+)-arenarol.341  The Okinawan sponge 
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Dactylospongia elegans yielded dactyloquinones C–E 351–353.342  A sulfated hydroquinone, 
phuklona sulfate 354 that displayed modest cytoprotection against HIV-1, was obtained from a 
Haliclona species collected in Thailand.343  An Okinawan Axinyssa species contained the 
monocyclic sesquiterpene (E)-3-isocyanobisabolane-7,10-diene 355 that is toxic to brine shrimp,344 
while exiguamide 356 from a Japanese collection of Geodia exigua inhibited sea urchin 
embryogenesis.345  A Jamaican specimen of Myrmekioderma styx yielded styxones A 357 and B 358 
as well as the degraded terpenoid styxlactone 359.346  Axinyssa ambrosia, collected from the 
Caribbean coast of Columbia, was the source of two nitrogenous eudesmane-type sesquiterpenes, 
360 and 361.  Compound 360 was cytotoxic to P388, HT-29 and A-549 cell lines and the polyps of 
the scleractinian coral Madracis mirabilis.347  A total synthesis of the spirocyclic sesquiterpene (+)-
axenol, originally isolated from an Eurypon sp. of sponge from New Zealand,348 has been achieved 
via a “one-pot” reaction.349  Kalihinene X 362, originally isolated from Acanthella cavernosa,350 was 
synthesised stereoselectively establishing the absolute stereochemistry.351  Seven tricyclic 
diterpenes, the gagunins A–G 363–369, with widely varying cytotoxicity were obtained from a 
Korean Phorbas species.352  A quite remarkable number of new diterpenes, the cyanthiwigins E to 
AA 370–392, with cytotoxic and anti-HIV–1 activity were obtained from the Jamaican sponge 
Myrmekioderma styx.353  A Vanuatuan collection of an Axinella species yielded the tetracyclic 
diterpene N-formyl-7-amino-11-cycloamphilectene 393.354  A Korean collection of a sponge of the 
genus Sarcotragus was found to contain two bisfuranoditerpenoids, sarcotins K 394 and L 395 
which displayed weak cytotoxicity.355  In the same report are also described the isolation of an 
additional seven pyrrolosesterterpenoids 396–402, five furanosesterterpenoids 403–407, and two 
trinorsesterterpenoids 408 and 409 which had varying levels of cytotoxicity.  The stereochemistries 
of the previously reported 410–412356 were revised on the basis of a re-interpretation of CD spectral 
data.355  Compound 411 was inadvertently drawn with (8Z) geometry in this and the previous 
report.355,356  A series of five sesterterpenoids, barangcadoic acid 413 and rhopaloic acids D–G 414–
417, were isolated from an Indonesian Hippospongia species.357  All compounds were found to 
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inhibit the protease activity of human RAS converting enzyme (hRCE1) and are the first natural 
products reported with this activity.  An Okinawan Luffariella species yielded two new luffariolides 
H 418 and J 419 that were found to be cytotoxic and antimicrobial.358  Three further cytotoxic 
sesterterpenes, thorectandrols C–E 420–422 were isolated from a Thorectandra species collected in 
Palau.359  Both the natural (+) and unnatural (–) enantiomers of cacospongionolide B, originally 
isolated from Fasciospongia cavernosa,360 have been synthesised; the natural enantiomer is more 
than twice as active as an inhibitor of sPLA2.361  Hyrtios erecta collected from the Egyptian Red Sea 
was found to contain salmahyrtisol A 423 and B 424 and 3-acetyl- and 19-acetyl-sesterstatin 425 
and 426, all of which showed significant cytotoxicity in human cancer cell lines.362  A species of 
Phyllospongia collected in Indonesia yielded the scalarane sesterterpenoids 427–433.363  Three 
further scalarane-type sesterterpenoids 434–436 were obtained from a Papua New Guinean 
specimen of Ledenfeldia frondosa.364  A Jamaican sample of Agelas sceptrum was found to contain 
the C29 steroid 437.365  A peroxy steroid, 9(11)-dehydroxyaxinysterol 438, from an Okinawan 
species of the genus Axinyssa, was found to inhibit the growth of several human cancer cell lines.344  
Three oxygenated sterols 439–441 were obtained from a collection of Polymastia tenax obtained 
from the Caribbean Coast of Columbia.  Compounds 439 and 440 were found to have significant 
cytotoxicity to a range of human and murine cancer cell lines.366  The absolute stereochemistry of 
contignasterol 442 was established by the preparation of MPA and MTPA esters as well as CD 
curve analysis, confirming the customary steroid configuration.367  A polyoxygenated steroid, 
clathriol 443, also with anti-inflammatory activity, was obtained from a New Zealand collection of 
Clathria lissosclera.368  The abeo-sterol orostanal, recently isolated from Stelletta hiwasaensis,369 
has been synthesised from hyodeoxycholic acid.370  An Indonesian specimen of Petrosia strongylata 
yielded two thymidine phosphorylase inhibiting sulfated sterols, lembehsterols A 444 and B 445.371  
Four new plakinamine type steroidal alkaloids 446–449 have been isolated from a Vanuatuan 
Corticium species.372  The steroidal tetraglycoside, mycaloside A 450, was obtained from a Cuban 
specimen of Mycale laxissima.373  A Philippine specimen of Rhabdastrella globostellata yielded the 
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isomalabaricane type triterpenoids stellettins H 451 and I 452 along with the antipode 453 of (+)-
stellettin E374 originally isolated from a Stelletta species.375  (–)-Stellettin E and the previously 
reported stellettin B were found to be selectively cytotoxic towards a p21-deficient HCT cell line.375  
Both enantiomers (S,S) and (R,R) of the acyclic diketotriterpene 454, originally isolated from 
Hyrtios erectus,376 have been synthesised asymmetrically, establishing the absolute stereochemistry 
of the natural product as (R,R).377  Eight further raspacionins 455–462 were isolated from a Sicilian 
collection of Raspaciona aculeata; all were found to be both ichthyotoxic and cytotoxic.378  The 
triterpenoid trisaccharide nobiloside 463, obtained from the Japanese sponge Erylus nobilis, is a 
neuraminidase inhibitor.379   
 
8 Coelenterates 
 
There was a slight increase in the number of metabolites reported from coelenterates in 2002.  The 
examples reported continue to be dominantly of terpenoid biogenesis.  Bioassay guided 
fractionation of extracts obtained from an Indian Ocean collection of the soft coral Lobophytum 
crassum afforded ceramide 464 as a moderately antibacterial component.380  Specimens of the soft 
coral Sinularia sp. collected from the Andaman and Nicobar Islands contained the ceramides 465 
and 466.381  Cervicoside 467, a new glycoside, was isolated from a Chinese collection of Sinularia 
cervicornis.382  In a study of soft corals from the Karwar region of India, xanthine 468 and pyrazole 
469 were isolated from Echinomuraceae splendens.383  New examples of cadinene-skeleton 
sesquiterpenes, xenitorins A–F 470–475, were isolated from a Taiwanese collection of Xenia 
puerto-galerae.384  The relative stereochemistries of 470–475 were secured by NOESY NMR 
experiments.  Xentorins A 470 and E 474 exhibited cytotoxicity towards the A-549 and P388 
tumour cell lines.  The structure and absolute stereochemistry of alcyopterosin E 476, a nitrate 
ester-containing sesquiterpene isolated from a sub-Antarctic collection of Alcyonium paessleri,385 
was secured by total synthesis.386  Subergorgiol 477 and 2β-acetoxysubergorgic acid 478 were 
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isolated from Taiwanese collections of Subergorgia suberosa.387  Relative stereochemistry was 
determined by NOESY NMR experiments.  Both 477 and 478 failed to exhibit cytotoxicity towards 
either KB or HeLa tumour cells, while subergorgic acid methyl ester, also isolated from the extract, 
exhibited mild cytotoxicity towards the HeLa cell line.  A racemic synthesis of pathylactone A 479, 
isolated from the soft coral Paralemnalia thyrsoides,388 and 1-epi-pathylactone A has raised doubts 
about the spectral assignments of the norsesquiterpene natural product.389  A further study of a 
Taiwanese collection of Subergorgia suberosa yielded the sesquiterpenes suberosols A–D 480–
483.390  Relative stereochemistries were determined by NOESY NMR experiments.  All four 
metabolites exhibited cytotoxicity towards the P388 murine leukaemia cell line while suberosols C 
482 and D 483 also exhibited cytotoxicity towards the A-549 and HT-29 tumour cell lines.  The 
first chemical study of the soft coral Lemnalia flava, collected off Mombasa, Kenya, has yielded 
lemnaflavoside 484 and three monoacetate derivatives 485–487.391  seco-Sethukarailin 488 was 
isolated from a collection of Sinularia dissecta from the Mandapam Coast, South India.392  
However, the compound may be an artifact arising from the use of methanol in the extraction 
process.  The Caribbean sea whip Pseudopterogorgia elisabethae was the source of ileabethin 489, 
a diterpene representing the first example of the ileabethane skeleton.393  Relative stereochemistry 
was ascertained through the interpretation of NOESY NMR data.  The absolute configuration of 
elisabethin C 490, a bisnorditerpenoid also isolated from P. elisabethae,394 has been secured by total 
synthesis.395  Three cytotoxic prostanoids, claviridenones E–G 491–493, were isolated from a 
Taiwanese collection of Clavularia viridis.396  Claviridenone B exhibited pronounced cytotoxicity 
towards the A-549, HT-29 and P388 cell lines.  The same publication also reported the isolation of 
cembranoid claviolide 494 from a Taiwanese collection of C. violacea.  An Okinawan collection of 
C. viridis yielded the prostanoid-related oxylipins tricycloclavulone 495 and clavubicyclone 496.397  
Relative stereochemistries of both compounds were principally determined by interpretation of 
NOESY NMR data, with the exception being a biogenetic argument that was used to assign the 
configuration of the sidechain acetoxy stereogenic centre.  Clavubicyclone 496 exhibited mild 
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cytotoxicity towards MCF-7 and OVCAR-3 tumour cell lines.  Bioassay-directed fractionation of a 
Taiwanese collection of the soft coral Cespitularia hypotentaculata yielded diterpenes cespitularins 
A–D 497–500, a norditerpene cespitularin E 501 and three further diterpenes, cespitularins F–H 
502–504, with a novel skeleton.398  Variable potency and selectivity was observed for the eight 
compounds towards tumour cell lines A-549, HT-29 and P388.  Two new dolabellane-type 
diterpenoids 505 and 506, as well as the known diterpene claenone 507,399 were isolated from an 
Okinawan collection of Clavularia species.400  The relative stereochemistries of 505 and 506 were 
secured by X-ray analysis, with absolute stereochemistry in both cases being inferred by the co-
occurrence of 507 which has defined absolute configuration.401  The facile chemical conversion of 
507 to 506 suggested that 506 was an artifact of isolation.  Moderate in vitro cytotoxicity towards 
tumour cell lines was observed for 506.  Clavularia koellikeri collected in Okinawa yielded two 
cembrane diterpenoids 508 and 509 and a dolabellane diterpene 510.402  The absolute configuration 
of 508 was secured by comparison with the known enantiomer,403 the relative stereochemistry of 
509 was determined by interpretation of NOESY NMR data while the absolute configuration of 510 
was obtained by NOESY NMR experiments, preparation of Mosher esters and comparison with the 
known absolute stereochemistry of the related metabolite stolonidiol.  Diterpene 508 was found to 
exhibit cytotoxicity to a wide range of tumour cell lines.  Investigation of the chemistry of Eunicea 
pinta collected from San Andrés Island, Colombia led to the report of eight γ-cembranolide-type 
diterpenes, 12-epieupalmerone 511 and uprolides H–K 512–515, K acetate 516, L 517 and M 
518.404  The structure and stereochemistry of 511 was established by X-ray analysis, which in turn 
led to a correction of the stereochemistry of the co-occurring diterpene succinolide 519.405  The 
structure and relative stereochemistry of uprolide H 512 was also secured by X-ray analysis, 
allowing the stereochemistries of 513–518 to be determined by NOESY NMR experiments.  The 
presence of (6E) geometry and a hydroperoxide group at C-8 in 512 also precipitated a revision of 
the structures of uprolide B 520,406 uprolide B acetate 521,406 uprolide B diacetate 522,406 8-epi-
uprolide B 523,406 8-epi-uprolide B acetate 524,406 8-epi-uprolide B diacetate 525,406 12,13-
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bisepiuprolide B 526,407 12,13-bisepiuprolide B acetate 527,407 uproeunicin 528,407 uprolide C 
529,406 uprolide C acetate 530406 and uproeuniolide 531.407  A Madagascan collection of 
Sarcophyton sp. was the source of cembrane diterpenes 532 and 533.408  The relative 
stereochemistry of 533 was deduced by interpretation of NOESY NMR data.  An Australian 
collection of Sarcophyton sp. yielded cembranes 534–537 as two pairs of stereoisomers.409  
Cembrane 534 is a previously reported semi-synthetic compound with defined absolute 
stereochemistry which in turn allowed the determination of absolute configuration for 535.  The 
absolute stereochemistries of 536 and 537 were established by the preparation of Mosher ester 
derivatives of 536.  Both 534 and 535 inhibited ligand binding to rat-brain adenosine A1 receptors.  
Scabrolides A–D 538–541 were isolated from a Taiwanese collection of Sinularia scabra.410  
Relative stereochemistries were determined by the use of NOESY NMR experiments.  Norditerpene 
540 exhibited mild cytotoxicity towards KB and Hepa59T/VGH tumour cell lines.  The structure 
and relative stereochemistry of cembrane 542, isolated from the soft coral Sinularia tenella, was 
established by X-ray analysis.411  Milolides G 543, 16-acetoxymilolide G 544, H–M 545–550, 16-
hydroxymilolide M 551, 16-acetoxymilolide M 552, milolide N 553 and 16-acetoxymilolide N 554 
were isolated from a collection of Briareum stechei from Yap, Micronesia.412  Relative 
stereochemistries were deduced by interpretation of NOESY NMR data.  Artificial cultures of 
Erythropodium caribaeorum were found to produce a range of diterpenes including the antimitotic 
agent eleutherobin and aquariolide A 555.413  Inspection of ROESY NMR data and comparison with 
known related compounds led to the proposed absolute stereochemistry of 555.  A Caribbean 
collection of the same gorgonian species led to the isolation of six new briarane diterpenes, 
erythrolides L–Q 556–561.414  Relative stereochemistries were established by interpretation of 
NOESY NMR data and by an X-ray analysis of 560.  The structure and absolute stereochemistry of 
juncenolide A 562, a mildly cytotoxic briarane diterpene isolated from a Taiwanese collection of 
Junceella juncea, was also established by X-ray analysis.415  Two full accounts have been given of 
the structural and stereochemical reassessments of sclerophytins A 563 and B 564.  Strong 
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circumstantial evidence is also provided for suggested structural revisions of several other 
sclerophytin-type diterpenes.416,417  A Far-Eastern collection of the gorgonian Plumarella sp. was the 
source of diterpenes plumarellide 565 and a possible artifact, the ethyl ester of plumarellic acid 
566.418  Relative stereochemistry was deduced from NOESY NMR data and both compounds 
exhibited mild haemolytic activity towards mice blood erythrocytes.  Pachyclavulariaenones D–G 
567–570 were isolated from a Taiwanese collection of Pachyclavularia violacea.419  The relative 
configurations of the compounds were secured by NOESY NMR experiments and an X-ray analysis 
of 569.  570 exhibited mild cytotoxicity.  An Indian Ocean collection of Sinularia sp. was the 
source of horiolide 571.420  Cyclobutenbriarein A 572 and five new examples of briarane skeleton 
diterpenes 11-hydroxybrianthein V 573, 11-hydroxybrianthein U 574, 11-hydroxybrianthein Y 575, 
3,4-dihydro-11-hydroxybrianthein V 576 and 3,4-dihydro-11-hydroxybrianthein U 577 were 
isolated from a Bahamian collection of Briareum asbestinum.421  The absolute configuration of 573 
was secured by an X-ray analysis while the relative stereochemistries of the other compounds were 
established by interpretation of NOESY NMR data.  An Indonesian collection of Xenia sp. yielded 
xeniolide F 578 and 9-hydroxyxeniolide F 579.  The relative stereochemistries were established by 
NOESY NMR experiments.422  Seven mildly cytotoxic xenicane-skeletoned diterpenes 580–586 
were isolated from Xenia umbellata collected off Taiwan.423  Secosterol 587 was reported from 
Pachyclavularia violacea collected near Sulawesi Island, Indonesia.424  The degraded pregnanes 
muricenones A 588 and B 589, were isolated from Muricea sp. collected in the Bay of Mazatlán, 
Mexico.425  The collection of Eunicea pinta from San Andrés Island, Colombia that afforded 
diterpenes 511–518 (vide supra) also yielded the saponin 590 which was characterised by X-ray 
analysis of the peracetate derivative.404  Saponin 591 was isolated from Lobophytum sp. collected 
from Sanya Bay, Hainan Island.426  The Taiwanese collection of Clavularia viridis that yielded 
prostanoids 491–493 (vide supra) also afforded three cytotoxic steroids, stoloniferones E–G 592–
594.396  Both the (20R) and (20S) stereoisomers of 595, isolated from the octocoral Dendronephthya 
sp.,427 have been prepared leading to the conclusion that the natural product has the (20S) 
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configuration.428  Nephthea bayeri, collected off Nanji Island China, yielded nanjiols A–C 596–
598.429  The structure of 22,23-dimethylcholest-5-en-3β-ol 599, isolated as the major sterol 
component of an Andaman and Nicobar Island collection of Sinularia species, must remain 
tentative as it was derived solely from mass fragmentation analysis of the monoacetate derivative.381  
A study of Japanese collections of Isis hippuris led to the isolation of steroids 600–610430 in 
addition to the previously reported 611.431  X-ray analysis established the stereochemistries of 611 
and 610, the latter result also establishing the stereochemistry of 612, previously reported from the 
same species.432  Most of the compounds showed moderate cytotoxicity towards drug-resistant cells 
expressing P-gp but not against cells expressing multidrug resistance protein-1 (MRP-1).  Further 
investigation of a Korean collection of the stony coral Montipora sp. yielded diacetylenes 613–615 
of which 615 was the most potent cytotoxin towards a range of tumour cell lines.433  The structures 
proposed for cladocorans A 616 and B 617, isolated from the Mediterranean anthozoan Cladocora 
cespitosa,434 are in question as spectroscopic data of synthetic material were not identical to data 
reported for the natural products.435  Ecdysteroid zoanthusterone 618 was isolated from a Thai 
collection of Zoanthus species.436  Tridentatols D–H 619–623 were isolated from the marine hydroid 
Tridentata marginata collected off North Carolina.437  Enzyme-mediated hydrolysis of the sulfate 
esters leads to the corresponding phenols, which include the potent feeding deterrent 624.  The sea 
anemone Anthopleura pacifica yielded ceramide (4E,8E)-spingol-n-hexadecamide 625.438  The 
solution structure of equinatoxin II, a 19.8 kDa cytolysin isolated from the Mediterranean anemone 
Actinia equina,439 has been determined by NMR analysis.440  The structure provides some clues as to 
how the peptide may bind to cell membranes and form pores, while a separate study has utilised 
lipid monolayers and surface plasmon resonance to further examine the events leading to pore 
formation.441  A polypeptide toxin, PsTX-20A, of molecular mass 20 kDa was purified from an 
Okinawan collection of the anemone Phyllodiscus semoni.442  Radianthus macrodactylus, collected 
in the Seychelles, yielded RTX-A, RTX-S and RTX-G, three high molecular weight (20 kDa) 
cytolysins, two low molecular weight cytolysins, RmI (5100 Da) and RmII (6100 Da) and InI, a 
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7100 Da trypsin inhibitor.443  The first total syntheses of montipyridine444 and montiporynes A and 
B,445 metabolites of the stony coral Montipora species,446,447 have been reported.  Further 
investigation of the diterpene glycoside lemnabourside, originally isolated from the soft coral 
Lemnalia bournei,448 has shown it to be an inhibitor of 5α-reductase and to exhibit antiproliferative 
activity via the caspase-3 apoptotic pathway.449  The sodium channel toxins Bg II and Bg III, 
isolated from the sea anemone Bunodosoma granulifera,450 have been found to be especially potent 
towards insect sodium channels.451 
 
9 Bryozoans 
 
Despite their promise as excellent sources of novel, bioactive metabolites, only a handful of new 
compounds have been reported from bryozoans.  Most of these are alkaloids.  Four new 
bromotryptamine derivatives 626–629 have been isolated from the North Sea bryozoan Flustra 
foliacea collected in German waters, and the complete 13C NMR spectral data for the known 
compound flustrabromine452 have been reported for the first time.453  A sample of F. foliacea 
collected in the southern North Sea also yielded deformylflustrabromine 628 which displayed 
moderate cytotoxicity against the HCT-116 cell line.454  The complete 1H and 13C NMR assignments 
for the F. foliacea alkaloids dihydroflustramine C,455 flustramine A,456 flustramine E,457 
debromoflustramine B,457 and flustramine B456 have been published, reconciling deficiencies and 
ambiguities from earlier literature assignments.458  The marine bryozoan Amathia convoluta 
collected from the East coast of Tasmania, was the source of the tribrominated alkaloids, 
convolutamine H 630 and convolutindole A 631.  Compounds 630 and 631 displayed potent and 
selective activity against Haemonchus contortus, a parasitic nematode of ruminants.459  Watersipora 
subtorquata from Tsutsumi Island, Japan was the source of bryoanthrathiophene 632.  This 
compound 632 exhibited potent antiangiogenic activity on bovine aorta endothelial cell (BAEC) 
proliferation.460  Three disulfides, pentaporins A–C 633–635, have been isolated from the 
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Mediterranean bryozoan Pentapora fascialis.  Energy dispersive X-ray analysis assisted in the 
determination of the existence of sulfur atoms.  The pentaporins 633–635 displayed anthelmintic 
activity against Trichinella spiralis.461  Several synthetic firsts have also been reported for bryozoan 
metabolites: the total syntheses of dihydroflustramine C455 and flustramine E457 have been 
achieved,462 as has the total synthesis of amathaspiramide F,463 an alkaloid from a New Zealand 
collection of Amathia wilsoni.464  Asymmetric syntheses of amathamides A and B, alkaloids from 
the bryozoan A. wilsoni collected in Tasmania,465 have been accomplished starting from 3-
hydroxybenzaldehyde.466 
 
10 Molluscs 
 
Fewer examples of new metabolites were reported from molluscs in 2002 than during the time 
period of the previous review.  The absolute stereochemistries of membrenones A–C 636–638, γ-
dihydropyrone-containing polypropionates isolated from the skin of the Mediterranean mollusc 
Pleurobranchus membranaceus,467 have been determined by stereocontrolled syntheses of the 
enantiomers.468  The stereochemical assignment of 638 is a correction of an earlier synthetic effort469 
necessitated by the conclusion that the sign of the optical rotations of 637 and 638 were misreported 
in the original isolation publication.467  Stereoselective syntheses have led to correction of the 
relative stereochemistry and established the absolute stereochemistry of siphonarienolone 639 and 
siphonarienedione 640,470 polypropionates originally isolated from the mollusc Siphonaria grisea.471  
The first synthesis of siphonarin B 641 has confirmed the absolute stereochemistry of the 
metabolite,472 isolated from the molluscs Siphonaria zelandica and S. atra.473  The structure and 
stereochemistry of a new polychlorinated sulfolipid 642 was reported from collections of the mussel 
Mytilus galloprovincialis made in the Adriatic Sea.474  The relative stereochemistry of 642 was 
established by 1H-13C and 1H-1H coupling constant analysis while absolute stereochemistry was 
established by the preparation and analysis of Mosher MTPA esters.  Mild cytotoxicity to murine 
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fibrosarcoma and monocyte/macrophage cell lines was observed for 642.  In a separate study of the 
same mollusc species, LC-MS/MS was used to identify a new yessotoxin analogue 643 designated 
noroxoYTX.475  The novel chlorinated pyrrolidone 644 was isolated from extracts of a Philippino 
collection of the dorid nudibranch Asteronotus cespitosus.476  As similar metabolites have been 
reported previously from the sponge Dysidea herbacea, the study concluded that the carnivorous 
mollusc in question acquired the metabolite as part of its diet as opposed to de novo synthesis.  A 
new member to the malyngamide series of metabolites, malyngamide S 645, was reported from a 
New Zealand collection of the sea hare Bursatella leachii.477  The compound also exhibited mild 
cytotoxicity and anti-inflammatory activities.  Kulokekahilide-1 646 is a moderately cytotoxic 
depsipeptide isolated from the mollusc Philinopsis speciosa collected off Pupukea, O'ahu.478  The 
absolute stereochemistry of 646 was determined by degradation combined with Marfey analysis as 
well as the synthesis of all stereoisomers of the two unusual amino acids, 4-phenylvaline and 3-
amino-2-methylhexanoic acid.  Bursatellanin-P, a 60 kDa protein was purified from the purple ink 
of the sea hare Bursatella leachii.479  The protein exhibited anti-HIV activity.  In an intriguing twist 
to the usual natural product isolation paradigm, PCR amplification, using primers of the α-
conotoxin gene sequence, of genomic DNA from the predatory marine snail Conus geographus 
yielded a single specific α-conopeptide gene product.480  Subsequent cloning and sequencing 
identified the α-conotoxin GIC sequence.  The predicted mature toxin, a 16-amino acid peptide, 
was then synthesised and found to act as a potent antagonist of the neuronal nicotinic receptor.  The 
biosynthesis of 2,6-dimethyl-5-heptenal, a volatile component of skin extracts of the dendronotid 
nudibranch Melibe leonina,481 has been investigated using stable isotope incorporation 
experiments.482  Successful incorporation of 13C demonstrated that the metabolite was the product of 
de novo terpenoid biosynthesis by the nudibranch.  The first enantiospecific synthesis of (–)-9-
pupukeanone 647, a degradation product of the volatile defensive isonitrile 9-isocyanopupukeanane 
648 isolated from the nudibranch Phyllidia varicosa,483 has been reported.484  The synthesis 
confirms the absolute stereochemistry of the pupukeanane skeleton.  The absolute stereochemistry 
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of ibhayinol 649, a sesquiterpenoid metabolite isolated from a South African collection of the sea 
hare Aplysia dactylomela,485 was established by X-ray analysis.486  MS-MS studies have firmly 
established the position of the methyl ester moiety in the purple pigment aplysiaviolin 650, isolated 
from a Tasmanian collection of the sea hare Aplysia parvula.173  This study included an 
investigation of the sea hare’s algal diet Laurencia filiformis which revealed the presence of the 5-
acetate derivative 168 of prepacifenol, as well as prepacifenol and a range of other known 
metabolites (vide supra).  Sardinian collections of the sea hare Aplysia punctata afforded a range of 
metabolites including four new diterpenes, 651–654, and three new sesquiterpenes 655–657.487  
Relative stereochemistries of 651–657 were secured by NOESY NMR experiments – the absolute 
configurations were not established.  A progesterone homologue 658 was isolated from the skin of 
the dorid nudibranch Aldisa smaragdina collected off Cabo Cope, Spain.488  The absolute 
stereochemistry was secured by synthesis from stigmasterol. 
The first total syntheses of aplyolides B–E, ichthyotoxic macrolides isolated from the skin 
of sea hare Aplysia depilans,489 have been reported confirming the absolute stereochemistry reported 
for the metabolites.490,491  A new synthesis of 3-isocyanotheonellin, a nitrogenous bisabolene 
sesquiterpene isolated from a Sri Lankan collection of the nudibranch Phyllidia sp.,492 was also 
amenable to the synthesis of related compounds all of which exhibited potent in vitro antifouling 
activity towards barnacle larvae.493  (–)-Doliculide, a cytotoxic depsipeptide isolated from a 
Japanese collection of the sea hare Dolabella auricularia,494,495 exhibits cytotoxicity by enhancing 
actin assembly.496  
 
11 Tunicates (ascidians) 
 
A similar number of new metabolites were reported in 2002 compared to 2001 and they continue to 
be dominantly amino acid-derived.  The inhibitor of matrix metalloproteinase 2 (MMP2) from an 
ascidian of the family Polyclinidae collected off Kii Peninsula, Western Japan was identified as 
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sodium 1-(12-hydroxy)octadecanyl sulfate 659.497  MTPA ester analysis indicated that 659 occurs 
naturally as a 55:45 mixture of the (12R) and (12S) enantiomers.  Synthesis from (R)-12-
hydroxystearic acid confirmed the structure of 659.  Both natural and synthetic material inhibited 
MMP2 with equal potency.  The absolute stereochemistry of lobatamide C 660, a cytotoxic 
macrolide isolated from Aplidium lobatum collected off the southwestern coast of Australia,498 has 
been defined by stereospecific synthesis.499  A novel triglycosylceramide derivative, sulcaceramide 
661, was reported from a Mediterranean collection of the ascidian Microcosmus sulcatus.500  The 
structure was solved by a combination of spectroscopic techniques and degradation/derivatisation 
studies.  Two unusual 1,2,3-trithiocane derivatives, 662 and 663 were isolated from the ascidian 
Perophora viridis collected off the Atlantic coast of North Carolina.501  Relative stereochemistries 
were deduced from NOESY NMR experiments while MTPA derivatisation of the hydroxyl at C-7' 
helped secure the absolute configuration of 662.  Both compounds exhibited mild antibacterial 
activity as well as toxicity towards brine shrimp.  The total synthesis of a stereoisomer of bistramide 
C, a cytotoxic polyether isolated from the ascidian Lissoclinum bistratum,502 combined with 
chiroptical analysis led to the proposal of 664 as the predicted relative and absolute configuration of 
the natural product.503  The relative and absolute stereochemistries of didemnaketals B 665 and C 
666, reported from an undescribed Palauan ascidian of the genus Didemnum,504,505 were established 
by a combination of degradation and derivatisation experiments.506  The structure of (+)-
didemniserinolipid B 667, a serinolipid isolated from an Indonesian collection of Didemnum sp.,507 
has been revised to the 31-sulfate and the relative and absolute configuration of the natural product 
established by synthesis.508  A new member of the tunichrome family of modified peptides, 
tunichrome Sp-1 668 was isolated from the hemocytes of Styela plicata, collected in Mission Bay, 
California.509  The sequence of 668 was determined by Edman degradation while stereochemistry 
was determined by acid hydrolysis followed by derivatisation and GC-MS and HPLC analysis.  The 
ascidian Didemnum molle, collected at Ibo Island north of Mozambique, was the source of the 
cycloheptapeptide cyclodidemnamide B 669.510  Hydrolysis followed by Marfey's derivatisation and 
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HPLC analysis allowed determination of configuration at many of the stereogenic centres with final 
confirmation being achieved by total synthesis.  Localisation studies of the related cyclic peptides 
patellamides A-C suggested that the natural products are distributed throughout the tunic of the 
ascidian Lissoclinum patella and not located in the Prochloron sp. symbiotic cyanobacteria.511  
Halocidin was isolated as an antimicrobial peptide (3443 Da) from the hemocytes of the solitary 
ascidian Halocynthia aurantium.512  Cloning of a peptide precursor from a cDNA library prepared 
from pharyngeal tissues of the tunicate Styela clava identified clavaspirin as a 23-residue 
antibacterial peptide.513  Synthetic clavaspirin inhibited the growth of Gram-positive and negative 
bacteria, permeabilised E. coli membranes and was potently haemolytic towards human and bovine 
erythrocytes.  Polyclonal antibodies, raised against clavanin A, have been used to locate the 
clavanin family of antibacterial peptides in the eosinophilic granulocytes and macrophages of the 
ascidian Styela clava.514  Lepadins D 670, a salt of 670 with an unidentified counterion, E 671 and F 
672 were isolated as antiplasmodial and antitrypanosomal alkaloid constituents of a Didemnum sp. 
ascidian collected from Stanley Reef, the Great Barrier Reef.515  The relative stereochemistries of 
substitution about the decahydroquinoline ring system in 670–672 were determined by NOESY 
NMR experiments and are illustrated here with the defined ring junction absolute stereochemistry 
of lepadin A.516  Lepadins F–H 672–674 were reported from extracts of the ascidian Aplidium 
tabascum collected from Swains Reef, Great Barrier Reef.517  In two separate accounts, the absolute 
stereochemistry of lepadiformine 675, a biologically active alkaloid isolated from the ascidians 
Clavelina lepadiformis and C. moluccensis,518,519 has been defined by stereoselective total 
synthesis.520,521  Two new 2-aminoimidazolone alkaloids, polyandrocarpamines A 676 and B 677, 
were isolated from a Fijian collection of the ascidian Polyandrocarpa sp. and the structures 
confirmed by synthesis.522  Coproverdine 678 is a cytotoxic alkaloid isolated by bioassay-directed 
fractionation of an unidentified ascidian collected at the Three Kings Islands, New Zealand.523  
Cytotoxicity towards a variety of murine and human tumour cell lines was observed.  Rubrolide M, 
recently isolated from a Spanish collection of the ascidian Synoicum blochmanni,524 was synthesised 
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using palladium-catalysed coupling methodology.525  The compound and related congeners were 
found to exhibit cytotoxicity towards human tumour cell lines.  The first syntheses of rhopaladins 
A–C and a new route to rhopaladin D have been reported,526 confirming the structures of the 
alkaloids isolated from a Rhopalaea sp. ascidian collected in Okinawa.527  Bioassay-directed 
fractionation of extracts of the New Zealand endemic ascidian Pycnoclavella kottae afforded the 
cytotoxic and anti-inflammatory alkaloids kottamides A–D 679–682.528  The structures were solved 
by spectroscopic techniques, including the use of 1H-15N 2D NMR experiments.  Sebastianines A 
683 and B 684 were isolated as biologically active pyridoacridine metabolites from a Brazilian 
collection of the ascidian Cystodytes dellechiajei.529  The relative stereochemistry of 684 was 
determined by interpretation of NOESY NMR data.  The cytotoxicities of both compounds towards 
human colon tumour cells were determined to be p53 dependent by use of p53 and p21 knockout 
cell lines.  The New Zealand ascidian Lissoclinum notti was found to contain the cytotoxic and 
antibacterial pyridoacridine alkaloids isodiplamine 685, cystodytin K 686 and lissoclinidine 687 in 
addition to several known related compounds including diplamine 688.530  Conversion of diplamine 
688 to lissoclinidine 687 was achieved by photochemical-induced isomerisation, but the natural 
product status of lissoclinidine was confirmed by rapid analysis of extract that was collected 
underwater and kept away from light.  Two new pyridoacridine alkaloids, kuanoniamines E 689 and 
F 690, and a putative biosynthetic precursor subarine 691 were isolated from a Singaporean 
collection of an unidentified ascidian.531  The mildly cytotoxic perophoramidine 692 was isolated 
from a Philippines collection of the ascidian Perophora namei.532  The carbon skeleton of 692 was 
established by analysis of HMBC and 2D INADEQUATE NMR data, while relative 
stereochemistry was determined by analysis of ROESY NMR data.  The structures of the pyrrole 
alkaloids polycitones A and B, originally isolated from a South African collection of the ascidian 
Polycitor sp. and Madagascan collections of Polycitor africanus,533,534 have been confirmed by 
synthesis.535  A new member of the lamellarin class of alkaloids, lamellarin β 693 was reported from 
a collection of the ascidian Didemnum sp.536  Investigation of the ascidian Eudistoma toealensis and 
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its predatory flatworm Pseudoceros sp., collected in Chuuk, Micronesia, yielded three new 
staurosporine derivatives 694–696.537  The absolute stereochemistries of 694–696 were established 
by comparison of CD data with those observed for staurosporine which has defined absolute 
stereochemistry.538  The study also led to revision of the absolute stereochemistries of derivatives 
697 and 698, previously reported from the same organisms.539  A study of the Thai ascidian 
Ecteinascidia thurstoni, using a KCN-pretreatment isolation procedure, afforded the known 
alkaloid ecteinascidin 770 699 and the novel analogue ecteinascidin 786 700.540  Both 699 and 700 
exhibited potent cytotoxicity towards tumour cell lines and growth inhibition of M. tuberculosis 
H37Ra.  The structure of 699 was confirmed in a separate study that also reported the stereoselective 
synthesis of ecteinascidin 743.541  The mechanism of cytotoxic action of ecteinascidin 743 has been 
reviewed.10  A Lissoclinum species collected off Hateruma Island, Okinawa contained 
haterumaimides J 701 and K 702 with the relative stereochemistry being deduced from NOESY 
NMR experiments.542  Both of the diterpene alkaloids exhibited potent cytotoxicity towards the 
P388 cell line.  A range of meroterpenoids including the new examples 703–706 were isolated from 
a Tarifa Island, Cádiz collection of the ascidian Aplidium conicum.543  The relative stereochemistry 
was determined by 1D and 2D NOE NMR experiments.  The sulfated steroid 707 was found to be 
responsible for sperm activation and attraction in Japanese collections of the ascidians Ciona 
intestinalis and C. savignyi.544  The absolute stereochemistry of (–)-longithorone A 708, a dimeric 
prenylated quinone isolated from the ascidian Aplidium longithorax,545,546 has been deduced in an 
elegant study that utilised Diels-Alder reactions in a biomimetic fashion.547  The structure of 
ritterazine M 709, a cytotoxic steroidal alkaloid isolated from the Japanese collection of the ascidian 
Ritterella tokioka,548 has been corrected by total synthesis.549,550  The structure presented for 709 in 
the synthesis papers contains an inadvertent error in the depicted C-25' stereochemistry of the 
isolated natural product – the correct structure of ritterazine M is shown in this review. 
Further investigation has shown that the mechanism of cytotoxic action of vitilevuamide, a 
bicyclic peptide isolated from Fijian collections of the ascidians Didemnum cuculliferum and 
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Polysyncraton lithostrotum,551 involves the inhibition of tubulin polymerisation possibly via 
interaction at a unique site.552  The in vivo antitumour activity of the dimeric disulfide alkaloid 
polycarpine, isolated from the ascidians Polycarpa clavata553 and P. aurata,554 and related synthetic 
analogues has been investigated.555  
 
12 Echinoderms 
 
Glycosylated ceramides and saponins continue to be the major classes of metabolites identified in 
echinoderms.  A full account of the isolation and characterisation of hedathiosulfonic acids A and 
B, isolated from a Japanese collection of the deep-sea urchin Echinocardium cordatum,556 has been 
reported.557  In addition, the compounds are the subject of a Japanese patent claiming the use of the 
compounds as antitumour, antibacterial and antifouling agents.558  Luidiacerebrosides A 710 and B 
711 were isolated from the starfish Luidia maculata collected in Hakata Bay, Fukuoka, Japan.559  
The stereochemistries of 710 and 711 were determined by degradation, fragment derivatisation and 
subsequent comparison with published data.  In a separate study of L. maculata, the same research 
group also reported the new ganglioside molecular species LMG-3, of which 712 is the major 
component.560  A collection of the Patagonian starfish Allostichaster inaequalis afforded two new 
glucosylceramides 713 and 714.561  Ten glucocerebrosides, HPC-3-A to HPC-3-J 715–724 and two 
glucocerebroside molecular species HPC-1 725 and HPC-2 726 were isolated from the Japanese sea 
cucumber Holothuria pervicax (Torafunamako).562  While the ceramide portions of HPC-1 and 
HPC-2 were comprised of extensive heterogeneous mixtures of alkyl homologues, use of reversed-
phase HPLC was effective in purifying 715–724, although regio-isomer ambiguity still exists.  All 
eight stereoisomers of pulcherrimine, a bitter principle isolated from the ovary of the sea urchin 
Hemicentrotus pulcherrimus,563 have been synthesised, leading to the revision of the structure for 
the (2'S,2R,4S) isomer 727.564  Investigation of the water-soluble components of crinoids collected at 
Goza, Japan afforded, in addition to a range of known quinones, the 6-O-sulfate of ptilometric acid 
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728 from Tropiometra afra macrodiscus and 729 from Oxycomanthus japonicus respectively.565  
The new sulfated steroid 730 was isolated from both Leptasterias alaskensis asiatica and L. fisheri, 
starfish collected at the Kiril Islands.566  A study of the starfish Diplopteraster multipes, also 
collected in the Far East, afforded a range of sterol sulfates including the new example 731.567  
Lysastroside A 732, a new steroidal glycoside was isolated from the starfish Lysastrosoma 
anthosticta, collected in the Sea of Japan.568  Ten new saponins, certonardosides A–J 733–742 were 
isolated from the starfish Certonardoa semiregularis, collected off the coast of Komun Island, 
Korea.569  The absolute configurations of the side chains were secured by the 1H NMR analysis of 
MTPA esters.  All compounds were evaluated for a range of antiviral properties towards HIV, 
HSV, CoxB, EMCV and VSV, but only mild potency was observed for 741 and 742.  Linckosides 
A 743 and B 744, neuritogenic steroidal glycosides, were reported from an Okinawan collection of 
the starfish Linckia laevigata.570  Both compounds induced neuronal differentiation in PC12 cells, 
with 744 being more potent.  Significant synergistic effects on NGF-induced neuronal 
differentiation in PC12 cells were also observed for 743 and 744.  Brine shrimp lethality-directed 
fractionation of the Patagonian starfish Anasterias minuta afforded anasterosides A 745 and B 
746.571  Anasteroside A 745 exhibited antifungal activity towards the plant pathogen Cladosporium 
cucumerinum, while 746 was inactive at all tested concentrations.  Hydrolysis of the crude 
triterpenoid glycosides purified from Andaman and Nicobar Islands, Indian Ocean collections of the 
sea cucumbers Holothuria nobilis and Bohadschia aff. tenuissima afforded the new genins 747–
749.572  Hemoiedemosides A 750 and B 751 are cytotoxic and antifungal triterpene glycosides 
isolated from the Patagonian sea cucumber Hemoiedema spectabilis.573  Hemoiedemoside A 750 
was more potent in the brine shrimp assay and more antifungal towards Cladosporium 
cucumerinum than 751, while the desulfated analogue of 750 was significantly less active in the 
same assays.  In the search for antagonists of the chemokine receptor subtype 5 (CCR5) as possible 
anti-HIV agents, bioassay guided fractionation of an Andaman and Nicobar Island collection of the 
sea cucumber Telenata ananas afforded two triterpene glycosides, 752 and 753.574  Both 
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compounds exhibited inhibitory activity in a CCR5 while no activity was observed towards the 
related receptor CXCR2.  
Two reports of new syntheses of echinoderm metabolites appeared in 2002.  A new route for 
the synthesis of (2S,2'R,3S,4R)-2-(2'-hydroxy-21'-methyldocosanoylamino)-1,3,4-pentadecanetriol, 
a ceramide sex pheromone isolated from the female Hair Crab, Erimacrus isenbeckii,575,576 was 
reported,577 while squaric acid ester-based methodology was used in a new synthesis of 
echinochrome A, a polyhydroxylated napthoquinone pigment commonly isolated from sea urchin 
spines.578  
 
13 Miscellaneous 
 
A series of flavones, the thalassiolins A–C 754–756 has been isolated from the Caribbean sea grass 
Thalassia testudinum (turtle grass).  Thalassiolins A–C 754–756 are HIV integrase inhibitors, of 
which thalassiolin A 754 is the most potent.579   
 
14 Conclusion 
 
Despite the greater number of people working in more diverse areas on marine natural products the 
rate of discovery of new compounds during 2002 (677) was only comparable to that for any year in 
the last decade or so (~718 per annum on average).  This could perhaps be explained by a steady 
state being reached where the greater effort is balanced against the difficulties of finding new 
compounds.  As in previous years new compounds from sponges and coelenterates dominate (37% 
and 20% respectively: see Figure 1).  Notable in 2002 was the decrease in compounds reported 
from molluscs (down from 7% to 2%).   
The presumed biogenetic origins of the new compounds for 2002 have been systematically 
assigned.  In assigning biogenetic origins divisions were made into peptide, terpenoid, alkaloid, 
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polyketide and shikimate categories.  Glycosides were classified by the origins of the aglycone; 
compounds of mixed biogenetic origins were classified as to the probable source of the majority of 
the carbon atoms; peptides, depsipeptides and peptide esters were grouped together separate from 
alkaloids, for which the criterion of a basic nitrogen was applied.  Non-basic aromatic compounds 
of shikimate or tryptophan origin were classified as shikimate.  Divisions were made within each 
category.  The terpenoids were divided up into mono, sesqui etc, but steroids and triterpenoids and 
higher terpenoids were clustered and a category of meroterpenoids introduced.  Alkaloids were sub-
divided into five categories that included compounds of polyketide, 3-alkylpyridine, shikimate, 
tryptophan as well as other origins.  Three subdivisions only were used for the polyketides – regular 
polyketides, compounds of fatty acid, ceramide or sphingolipid origin, and the macrolides. 
The overall biogenetic distribution is shown in Figure 2.  The dominant pathway is that of 
terpenoid biogenesis (48%), which is perhaps not surprising as the chemistry of the two largest 
groups examined, the sponges and coelenterates, is dominated by terpenoid compounds.  A more 
detailed breakdown of biogenetic origins is shown in Figure 3.  For clarity the algae are shown as 
just one grouping and compounds of direct shikimate origin have been omitted.  It is emphasised 
that these distributions are for compounds reported in 2002, and should not taken to necessarily 
reflect the distributions for all reported marine natural products. 
 
15 Acknowledgement 
 
We thank Ekkehard Unger for assistance in the collection of data for this review. 
 
16 References 
 
1 J. W. Blunt, B. R. Copp, M. H. G. Munro, P. T. Northcote and M. R. Prinsep, Nat. Prod. Rep., 
2003, 20, 1. 
 47 
2 A. H. Banner, P. J. Scheuer, S. Sasaki, P. Helfrich and C. B. Alender, Annals N.Y. Acad. Sci., 
1960, 90, 770. 
3 J. Lukomska, F. Kasprzykowski, L. Lankiewicz, and Z. Grzonka, Wiadomosci Chemiczne, 
2002, 56, 57. 
4 M. D. Vera and M. M. Joullié, Med. Res. Rev., 2002, 22, 102. 
5 A. B. Dounay and C. J. Forsyth, Curr. Med. Chem., 2002, 9, 1939. 
6 G. G. Harrigan and G. Goetz, J. Appl. Phycol., 2002, 14, 103. 
7 H. Luesch, G. G. Harrigan, G. Goetz, and F. D. Horgen, Curr. Med. Chem., 2002, 9, 1791. 
8 Y. Kishi, Tetrahedron, 2002, 58, 6239. 
9 M. Kalesse and M. Chirstmann, Synthesis, 2002, 8, 981. 
10 G. J. Aune, T. Furuta, and Y. Pommier, Anti Cancer Drugs, 2002, 13, 545. 
11 J. D. Scott and R. M. Williams, Chem. Rev., 2002, 102, 1669. 
12 K. J. Hale, M. G. Hummersone, S. Manaviazar, and M. Frigerio, Nat. Prod. Rep., 2002, 19, 
413. 
13 A. Clamp and G. C. Jayson, Anti Cancer Drugs, 2002, 13, 673. 
14 P. Sung, J. Sheu, and J. Xu, Heterocycles, 2002, 57, 535. 
15 R. G. S. Berlinck, Nat. Prod. Rep., 2002, 19, 617. 
16 Z. Jin, Z. G. Li, and R. Q. Huang, Nat. Prod. Rep., 2002, 19, 454. 
17 V. M. Dembitsky and M. Srebnik, Prog. Lipid Res., 2002, 41, 315. 
18 S. Hibino and T. Choshi, Nat. Prod. Rep., 2002, 19, 148. 
19 J. P. Michael, Nat. Prod. Rep., 2002, 19, 719. 
20 V. M. Dembitsky, Russ. J. Bioorg. Chem., 2002, 28, 170. 
21 V. M. Dembitsky, R. Smoum, A. A. Al-Quntar, H. A. Ali, I. Pergament, and M. Srebnik, 
Plant Sci., 2002, 163, 931. 
22 A. Kanazawa, Fish Sci., 2001, 67, 997. 
23 W. H. Gerwick and I. P. Singh, Lipid Biotechnology, 2002, 249. 
 48 
24 D. Skyler and C. H. Heathcock, J. Nat. Prod., 2002, 65, 1573. 
25 F. P. Marmsäter and F. G. West, Chem. Eur. J., 2002, 8, 4346. 
26 G. Pohnert and W. Boland, Nat. Prod. Rep., 2002, 19, 108. 
27 R. G. Kerr, A. C. Kohl, and J. M. Boehnlein, Chem. Pharm. Bull., 2002, 50, 149. 
28 C. J. P. Grimmelikhuijzen, M. Williamson, and G. N. Hansen, Can. J. Zool., 2002, 80, 1690. 
29 P. V. L. Rao, N. Gupta, A. S. B. Bhaskar, and R. Jayaraj, J. Environmental Biology, 2002, 23, 
215. 
30 P. J. Sung and M. C. Chen, Heterocycles, 2002, 57, 1705. 
31 P. R. Jensen and W. Fenical, Br. J. Pharmacol., 2002, 137, 293. 
32 A. Kelecom, An. Acad. Bras. Cienc., 2002, 74, 151. 
33 G. Anderluh and G. Menestrina, Mar. Biotechnol., 2002, 8, 131. 
34 J. D. Leblond and P. J. Chapman, J. Phycol., 2002, 38, 670. 
35 M. V. D'Auria, A. Zampella, and F. Zollo, Stud. Nat. Prod. Chem., 2002, 26, 1175. 
36 N. Lindquist, J. Chem. Ecol., 2002, 28, 1987. 
37 P. Proksch, R. A. Edrada, and R. Ebel, Appl. Microbiology and Biotechnology, 2002, 59, 125. 
38 A. M. S. Mayer and M. T. Hamann, Comp. Biochem. Physiol. C Toxicol. Pharm., 2002, 132, 
315. 
39 R. J. Quinn, P. de Almeida Leone, G. Guymer, and J. N. A. Hooper, Pure Appl. Chem., 2002, 
74, 519. 
40 E. L. Ghisalberti, Stud. Nat. Prod. Chem., 2002, 26, 425. 
41 M. E. Elyashberg, K. A. Blinov, A. J. Williams, E. R. Martirosian and S. G. Molodtsov, J. 
Nat. Prod., 2002, 65, 693. 
42 J. Lei and J. Zhou, J. Chem. Inf. and Computer Sciences, 2002, 42, 742. 
43 MarinLit database, Department of Chemistry, University of Canterbury: 
http://www.chem.canterbury.ac.nz/research/marinlit.htm 
44 T. Barsby, M. T. Kelly and R. J. Andersen, J. Nat. Prod., 2002, 65,1447. 
 49 
45 I. Ohtani, T. Kusuki, Y. Kashman and H. Kakisawa, J. Am. Chem. Soc., 1991, 113, 4092. 
46 T. Sugawara, M. Shibazaki, H. Nakahara and K. Suzuki, J. Antibiot., 1996, 49, 345. 
47 M. Ermolenko, Tetrahedron Lett., 1996, 37, 6711. 
48 N. I. Kalinovskaya, T. A. Kuznetsova, E. P. Ivanova, L. A. Romanenko, V. G. Voinov, F. 
Huth and H. Laatsch, Mar. Biotechnol., 2002, 4, 179. 
49 K. Barbeau, G. Zhang, D. H. Live and A. Butler, J. Am. Chem. Soc., 2002, 124, 378. 
50 L. Yang, R. Tan, Q. Wang, W. Huang and Y. Yin, Tetrahedron Lett., 2002, 43, 6545. 
51 R. N. Asolkar, R. P. Maskey, E. Helmke and H. Laatsch, J. Antibiot., 2002, 55, 893. 
52 D. Laurent, G. Guella, I. Mancini, M.-F. Roquebert, F. Farinole and F. Pietra, Tetrahedron, 
2002, 58, 9163. 
53 Z. Jiang, M.-O. Barret, K. G. Boyd, D. R. Adams, A. S. F. Boyd and J. G. Burgess, 
Phytochemistry, 2002, 60, 33. 
54 Y. Lin, H. Li, G. Jiang, S. Zhou, L. L. P. Vrijmoed and E. B. G. Jones, Indian J. Chem. Sect. 
B, 2002, 41, 1542. 
55 T. Yamada, C. Iwamoto, N. Yamagaki, T. Yamanouchi, K. Minoura, T. Yamori, Y. Uehara, 
T. Andoh, K. Umemura and A. Numata, Tetrahedron, 2002, 58, 479. 
56 H. Sakaki, H. Kaneno, Y. Sumiya, M. Tsushima, W. Miki, N. Kishimoto, T. Fujita, S. 
Matsumoto, S. Komemushi and A. Sawabe, J. Nat. Prod., 2002, 65, 1683. 
57 M. Chu, R. Mierzwa, I. Trumees, F. Gentile, M. Petel, V. Gullo, T.-M. Chan and M. S. Puar, 
Tetrahedron Lett., 1993, 34, 7537. 
58 Y. Usami, S. Aoki, T. Hara and A. Numata, J. Antibiot., 2002, 55, 655. 
59 B. W. Son, J. S. Choi, J. C. Kim, K. W. Nam, D. S. Kim, H. Y. Chung, J. S. Kang and H. D. 
Choi, J. Nat. Prod., 2002, 65, 794. 
60 M. Cueto, P. R. Jensen and W. Fenical, Org. Lett., 2002, 4, 1583. 
61 R. Jadulco, G. Brauers, R. A. Edrada, R. Ebel, V. Wray, Sudarsono and P. Proksch, J. Nat. 
Prod., 2002, 65, 730. 
 50 
62 J. Malmstrøm, C. Christophersen, A. F. Barrero, J. E. Oltra, J. Justicia and A. Rosales, J. Nat. 
Prod., 2002, 65, 364. 
63 T. Yamada, M. Iritani, K. Minoura, A. Numata, Y. Kobayashi and Y.-G. Wang, J. Antibiot., 
2002, 55, 147. 
64 A. Numata, M. Iritani, T. Yamada, K. Minoura, E. Matsumura, T. Yamori and T. Tsuruo, 
Tetrahedron Lett., 1997, 38, 8215. 
65 T. Yamada, M. Iritani, M. Doi, K. Minoura, T. Ito and A. Numata, J. Chem. Soc. Perkin 
Trans. 1, 2001, 3046. 
66 H. Nakamura, M. Ono, T. Yamada, A. Numata and H. Akita, Chem. Pharm. Bull., 2002, 50, 
303. 
67 H. Nakamura, M. Ono, Y. Shida and H. Akita, Tetrahedron:Asymmetry, 2002, 13, 705. 
68 Y. Kobayashi and Y. G. Wang, Tetrahedron Lett., 2002, 43, 4381. 
69 C. Takahashi, T. Takada, T. Yamada, K. Minoura, K. Uchida, E. Matsumura and A. Numata, 
Tetrahedron Lett., 1994, 35, 5013. 
70 T. Yamada, K. Minoura and A. Numata, Tetrahedron Lett., 2002, 43, 1721. 
71 M. Isaka, C. Suyarnsestakorn, M. Tanticharoen, P. Kongsaeree and Y. Thebtaranonth, J. Org. 
Chem., 2002, 67, 1561. 
72 C. Osterhage, G. M. König, U. Höller and A. D. Wright, J. Nat. Prod., 2002, 65, 306. 
73 C.-Y. Wang, B.-G. Wang, G. Brauers, H.-S. Guan, P. Proksch and R. Ebel, J. Nat. Prod., 
2002, 65, 772. 
74 S. S. Afiyatullov, A. I. Kalinovsky, T. A. Kuznetsova, V. V. Isakov, M. V. Pivkin, P. S. 
Dmitrenok and G. B. Elyakov, J. Nat. Prod., 2002, 65, 641. 
75 D. Abbanat, M. Leighton, W. Maiese, E. B. G. Jones, C. J. Pearce and M. J. Greenstein, J. 
Antibiot., 1998, 51, 296. 
76 G. Schlingmann, L. Milne and G. T. Carter, Tetrahedron, 2002, 58, 6825. 
 51 
77 R. A. Edrada, M. Heubes, G. Brauers, V. Wray, A. Berg, U. Gräfe, M. Wohlfarth, J. 
Mühlbacher, K. Schaumann, Sudarsono, G. Bringmann and P. Proksch, J. Nat. Prod., 2002, 
65, 1598. 
78 M. Daferner, T. Anke and O. Sterner, Tetrahedron, 2002, 58, 7781. 
79 M. Chinworrungsee, P. Kittakoop, M. Isaka, R. Chanphen, M. Tanticharoen and Y. 
Thebtaranonth, J. Chem. Soc. Perkin Trans. 1, 2002, 2473. 
80 W. Yin, Y. Lin, S. Zhou and L. L. P. Vrijmoed, Zhongshan Daxue Xuebao, Ziran Kexueban, 
2002, 41, 56. 
81 C. H. Liu, J. C. Meng, W. X. Zou, L. L. Huang, H. Q. Tang and R. X. Tan, Planta Med., 
2002, 68, 363. 
82 C. Osterhage, G. M. König, P. G. Jones and A. D. Wright, Planta Med., 2002, 68, 1052. 
83 H. Luesch, W. Y. Yoshida, G. G. Harrigan, J. P. Doom, R. E. Moore and V. J. Paul, J. Nat. 
Prod., 2002, 65, 1945. 
84 L. T. Tan, B. L. Márquez and W. H. Gerwick, J. Nat. Prod., 2002, 65, 925. 
85 H. Luesch, W. Y. Yoshida, R. E. Moore and V. J. Paul, Bioorg. Med. Chem., 2002, 10, 1973. 
86 H. Luesch, W. Y. Yoshida, R. E. Moore and V. J. Paul, Tetrahedron, 2002, 58, 7959. 
87 H. Sone, T. Kondo, M. Kiryu, H. Ishiwata, M. Ojika and K. Yamada, J. Org. Chem., 1995, 
60, 4774. 
88 H. Luesch, W. Y. Yoshida, R. E. Moore, V. J. Paul and S. L. Mooberry, J. Nat. Prod., 2000, 
63, 611. 
89 H. Luesch, W. Y. Yoshida, R. E. Moore and V. J. Paul, J. Nat. Prod., 2000, 63, 1437. 
90 K. Milligan, B. L. Marquez, R. T. Williamson and W. H. Gerwick, J. Nat. Prod., 2000, 63, 
1440. 
91 F. Yokokawa, H. Sameshima, D. Katagiri, T. Aoyama and T. Shioiri, Tetrahedron, 2002, 58, 
9445. 
 52 
92 H. Luesch, P. G. Williams, W. Y. Yoshida, R. E. Moore and V. J. Paul, J. Nat. Prod., 2002, 
65, 996. 
93 L. M. Nogle and W. H. Gerwick, J. Nat. Prod., 2002, 65, 21. 
94 J. B. MacMillan and T. F. Molinski, Org. Lett., 2002, 4, 1535. 
95 B. L. Marquez, K. S. Watts, A. Yokochi, M. A. Roberts, P. Verdier-Pinard, J. I. Jimenez, E. 
Hamel, P. J. Scheuer and W. H. Gerwick, J. Nat. Prod., 2002, 65, 866. 
96 J. R. P. Cetusic, F. R. Green, P. R. Graupner and M. P. Oliver, Org. Lett., 2002, 4, 1307. 
97 L. M. Nogle and W. H. Gerwick, Org. Lett., 2002, 4, 1095. 
98 P. G. Williams, W. Y. Yoshida, R. E. Moore and V. J. Paul, J. Nat. Prod., 2002, 65, 29. 
99 J. B. MacMillan and T. F. Molinski, Org. Lett., 2002, 4, 1883. 
100 H.-F. Wong, G. A. Williams and G. D. Brown, Phytochemistry, 2002, 60, 425. 
101 G. R. Pettit, Y. Kamano, C. L. Herald, A. A. Tuinman, F. E. Boettner, H. Kizu, J. M. 
Schmidt, L. Baczynskyj, K. B. Tomer, R. J. Bontems, J. Am. Chem. Soc., 1987, 109, 6883. 
102 H. Luesch, W. Y. Yoshida, R. E. Moore, V. J. Paul, S. L. Mooberry and T. H. Corbett, J. Nat. 
Prod., 2002, 65, 16. 
103 H. Sone, T. Shibata, T. Fujita, M. Ojika and K. Yamada, J. Am. Chem. Soc., 1996, 118, 1874. 
104 F. D. Horgen, E. B. Kazmierski, H. E. Westenburg, W. Y. Yoshida and P. J. Scheuer, J. Nat. 
Prod., 2002, 65, 487. 
105 P. G. Williams, W. Y. Yoshida, R. E. Moore and V. J. Paul, J. Nat. Prod., 2002, 65, 1336. 
106 R. T. Williamson, A. Boulanger, A. Vulpanovici, M. A. Roberts and W. H. Gerwick, J. Org. 
Chem., 2002, 67, 7927. 
107 M. Satake, M. Shoji, Y. Oshima, H. Naoki, T. Fujita and T. Yasumoto, Tetrahedron Lett., 
2002, 43, 5829. 
108 M. Satake, M. Murata and T. Yasumoto, J. Am. Chem Soc., 1993, 115, 361. 
109 H. Fuwa, N. Kainuma, K. Tachibana and M. Sasaki, J. Am. Chem. Soc., 2002, 124, 14983. 
110 H. Fuwa, M. Sasaki, M. Satake and K. Tachibana, Org. Lett., 2002, 4, 2981. 
 53 
111 J. Kobayashi, M. Ishibashi, T. Murayama, M. Takamatsu, M. Iwamura, Y. Ohizumi and T. 
Sasaki, J. Org. Chem., 1990, 55, 3421. 
112 T. Kubota, M. Tsuda and J. Kobayashi, J. Org. Chem., 2002, 67, 1651. 
113 J. Kobayashi, K. Shimbo, M. Sato and M. Tsuda, J. Org. Chem., 2002, 67, 6585. 
114 J. Kobayashi, H. Shigemori, M. Ishibashi, T. Yamasu, H. Hirota and T. Sasaki, J. Org. Chem., 
1991, 56, 5221. 
115 M. Ishibashi, Y. Ohizumi, M. Hamashima, H. Nakamura, Y. Hirata, T. Sasaki and J. 
Kobayashi, J. Chem. Soc. Chem. Comm., 1987, 1127. 
116 J. Kobayashi, M. Ishibashi, H. Nakamura, Y. Ohizumi, T. Yamasu, Y. Hirata, T. Sasaki, T. 
Ohta and S. Nozoe, J. Nat. Prod., 1989, 52, 1036. 
117 K. Shimbo, M. Tsuda, N. Izui and J. Kobayashi, J. Org. Chem., 2002, 67, 1020. 
118 J. Kobayashi, Nat. Prod. Rep., 2004, 21, xxx. 
119 J. Kobayashi, M. Ishibashi, H. Nakamura, Y. Ohizumi, T. Yamasu, T. Sasaki and Y. Hirata, 
Tetrahedron Lett., 1986, 27, 5755. 
120 R. E. Maleczka, L. R. Terrell, F. Geng and J. S. Ward III, Org. Lett., 2002, 4, 2841. 
121 B. Trost, J. D. Chisholm, S. J. Wrobleski and M. Jung, J. Am. Chem. Soc., 2002, 124, 12420. 
122 H. W. Lam and G. Pattenden, Angew. Chem. Int. Ed. Eng., 2002, 41, 508. 
123 J. Kobayashi, T. Kubota, T. Endo and M. Tsuda, J. Org. Chem., 2001, 66, 134. 
124 A. Fürstner, C. Aïssa, R. Riveiros and J. Ragot, Angew. Chem. Int. Ed. Eng., 2002, 41, 4763. 
125 Y. Hiraga, K. Kaku, D. Omoda, K. Sugihara, H. Hosoya and M. Hino, J. Nat. Prod., 2002, 65, 
1494. 
126 S. G. Toske, P. R. Jensen, C. A. Kauffman and W. Fenical, Tetrahedron, 1998, 54, 13459. 
127 L. Rivas, L. Quintero, J.-L. Fourrey and R. Benhida, Tetrahedron Lett., 2002, 43, 7639. 
128 F. Yokokawa and T. Shioiri, Tetrahedron Lett., 2002, 43, 8673. 
129 P. J. Proteau, W. H. Gerwick, F. Garcia-Pichel and R. Castenholtz, Experientia, 1993, 49, 
825. 
 54 
130 C. S. Stevenson, E. A. Capper, A. K. Roshak, B. Marquez, K. Grace, W. H. Gerwick, R. S. 
Jacobs and L. A. Marshall, Inflammation Res., 2002, 51, 112. 
131 C. S. Stevenson, E. A. Capper, A. K. Roshak, B. Marquez, C. Eichman, J. R. Jackson, M. 
Mattern, W. H. Gerwick, R. S. Jacobs and L. A. Marshall, J. Pharmacol. Exp. Ther, 2002, 
303, 858. 
132 M. Murakami, K. Makabe, S. Yamaguchi, S. Konosu and R. Walchi, Tetrahedron Lett., 1988, 
29, 1149. 
133 M. Abe, D. Inoue, K. Matsunaga, Y. Ohizumi, H. Ueda, T. Asano, M. Murakami and Y. Sato, 
J. Cell Physiol., 2002, 190, 109. 
134 E. Dorta, J. Darias, A. San Martín and M. Cueto, J. Nat. Prod., 2002, 65, 329. 
135 H.-E. Högberg, R. H. Thomson and T. J. King, J. Chem. Soc. Perkin Trans. 1, 1976, 1696. 
136 D. M. Estrada, J. D. Martín and C. Pérez, J. Nat. Prod., 1987, 50, 735. 
137 M. S. Ali, M. Saleem, R. Yamdagni and M. A. Ali, Nat. Prod. Lett., 2002, 16, 407. 
138 Y. Yoshii, S. Takaichi, T. Maoka, S. Hanada and I. Inouye, J. Phycol., 2002, 38, 297. 
139 A. K. Siddhanta, A. M. Goswami, B. K. Ramavat and B. Achari, J. Indian Chem. Soc., 2002, 
79, 843. 
140 Y. Takahashi, K. Itoh, M. Ishii, M. Suzuki and Y. Itabashi, Mar. Biol. (Berlin), 2002, 140, 
763. 
141 Z. Kamenarska, F. N. Yalçin, T. Ersöz, I. Çalis, K. Stefanov and S. Popov, Z. Naturforsch. C 
Biosci., 2002, 57, 584. 
142 E. Dorta, M. Cueto, A. R. Díaz-Marrero and J. Darias, Tetrahedron Lett., 2002, 43, 9043. 
143 M. Suzuki, H. Yamada and K. Kurata, J. Nat. Prod., 2002, 65, 121. 
144 H.-F. Tang, Y.-H. Yi, X.-S. Yao, Q.-Z. Xu, S.-Y. Zhang and H.-W. Lin, J. Asian Nat. Prod. 
Res., 2002, 4, 95. 
145 S.-H. Xu, L.-S. Ding, M.-K. Wang, S.-L. Peng and X. Liao, Youji Huaxue, 2002, 22, 138. 
146 F. Czapek, Lotos, 1912, 59, 250. 
 55 
147 S.-E. N. Ayyad and M. Deyab, Alexandria J. Pharm. Sci., 2002, 16, 27. 
148 J. Kimura and N. Maki, J. Nat. Prod., 2002, 65, 57. 
149 E. Dorta, M. Cueto, I. Brito and J. Darias, J. Nat. Prod., 2002, 65, 1727. 
150 S. Hayat, Atta-ur-Rahman, M. I. Choudhary, K. M. Khan and A. Abbaskhan, Chem. Pharm. 
Bull., 2002, 50, 1297. 
151 Y.-C. Chen, P. I. Tsai, W. Fenical and M. E. Hay, Phytochemistry, 1992, 32, 71. 
152 S. Ohira, A Kuboki, T. Hasegawa, T. Kikuchi, T. Kutsukake and M. Nomura, Tetrahedron 
Lett., 2002, 43, 4641. 
153 M.-N. Dave, T. Kusumi, M. Ishitsuka, T. Iwashita and H. Kakisawa, Heterocycles, 1984, 22, 
2301. 
154 K. Aoki, M. Takahashi, M. Hashimoto, T. Okuno, K. Kurata and M. Suzuki, Biosci. 
Biotechnol. Biochem., 2002, 66, 1915. 
155 M. Ochi, H. Kotsuki, K. Muraoka and T. Tokoroyama, Bull. Chem. Soc. Jpn., 1979, 52, 629. 
156 T. Laube, J. Schröder, R. Stehle and K. Seifert, Tetrahedron, 2002, 58, 4299. 
157 A. R. Díaz-Marrero, M. Cueto, E. Dorta, J. Rovirosa, A. San-Martín and J. Darias, Org. Lett., 
2002, 4, 2949. 
158 A. R. Díaz-Marrero, J. Rovirosa, J. Darias, A. San-Martín and M. Cueto, J. Nat. Prod., 2002, 
65, 585. 
159 A. R. Díaz-Marrero, M. Cueto, E. Dorta, J. Rovirosa, A. San-Martín and J. Darias, 
Tetrahedron, 2002, 58, 8539. 
160 J. Darias, J. Rovirosa, A. San-Martín, A. R. Diaz, E. Dorta and M. Cueto, J. Nat. Prod., 2001, 
64, 1383. 
161 V. H. Argandoña, J. Rovirosa, A. San-Martín, A. Riquelme, A. R. Díaz-Marrero, M. Cueto, J. 
Darias, O. Santana, A. Guadaño and A. González-Coloma, J. Agric. Food Chem., 2002, 50, 
7029. 
162 D. B. Stierle and J. J. Sims, Tetrahedron, 1979, 35, 1261. 
 56 
163 A. San-Martín and J. Rovirosa, Biochem. Syst. Ecol., 1986, 14, 459. 
164 R. J. Capon, L. M. Engelhardt, E. L. Ghisalberti, P. R. Jefferies, V. A. Patrick and A. H. 
White, Aust. J. Chem., 1984, 37, 537. 
165 J. S. Mynderse and D. J. Faulkner, J. Am. Chem. Soc., 1974, 96, 6771. 
166 M. D. Higgs, D. J. Vanderah and D. J. Faulkner, Tetrahedron, 1977, 33, 2775. 
167 M. Cueto, J. Darias, J. Rovirosa and A. San Martin, J. Nat. Prod., 1998, 61, 1466. 
168 M. Suzuki, Y. Takahashi, Y. Mitome, T. Itoh, T. Abe and M. Masuda, Phytochemistry, 2002, 
60, 861. 
169 Y. Takahashi, M. Daitoh, M. Suzuki, T. Abe and M. Masuda, J. Nat. Prod., 2002, 65, 395. 
170 D. Iliopoulou, C. Vagias, D. Galanakis, D. Argyropoulos and V. Roussis, Org. Lett., 2002, 4, 
3263. 
171 I. Brito, M. Cueto, E. Dorta and J. Darias, Tetrahedron Lett., 2002, 43, 2551. 
172 B. M. Howard and W. Fenical, Tetrahedron Lett., 1975, 1687. 
173 J. Jongaramruong, A. J. Blackman, B. W. Skelton and A. H. White, Aust. J. Chem., 2002, 55, 
275. 
174 G. Guella, D. Skropeta, I. Mancini and F. Pietra, Z. Naturforsch. B Chem. Sci., 2002, 57, 
1147. 
175 D. Iliopoulou, C. Vagias, C. Harvala and V. Roussis, Phytochemistry, 2002, 59, 111. 
176 D. Iliopoulou, V. Roussis, C. Pannecouque, E. De Clercq and C. Vagias, Tetrahedron, 2002, 
58, 6749. 
177 I. Brito, M. Cueto, A. R. Díaz-Marrero, J. Darias and A. San Martín, J. Nat. Prod., 2002, 65, 
946. 
178 M. L. Souto, C. P. Manríquez, M. Norte and J. J. Fernández, Tetrahedron, 2002, 58, 8119. 
179 H.-D. Yoo, S. O. Ketchum, D. France, K. Bair and W. H. Gerwick, J. Nat. Prod., 2002, 65, 
51. 
180 V. Bultel-Poncé, S. Etahiri and M. Guyot, Bioorg. Med. Chem. Lett., 2002, 12, 1715. 
 57 
181 J. P. Bergé, E. Debiton, J. Dumay, P. Durand and C. Barthomeuf, J. Agric. Food Chem., 
2002, 50, 6227. 
182 G. T. Carter, K. L. Rinehart Jr., H. L. Li, S. L. Kuentzel and J. L. Connor, Tetrahedron Lett., 
1978, 46, 4479. 
183 Y. Liu and G. W. Gribble, J. Nat. Prod., 2002, 65, 748. 
184 C. P. Falshaw, T. J. King, S. Imre, S. Islimyeli and R. H. Thomson, Tetrahedron Lett., 1980, 
21, 4951. 
185 R. K. Boeckman, J. Zhang and M. R. Reeder, Org. Lett., 2002, 4, 3891. 
186 D. Xiao, S. Deng and L. Zeng, Zhongshan Daxue Xuebao, Ziran Kexueban, 2002, 41, 111. 
187 I. Kuroda, M. Musman, I. I. Ohtani, T. Ichiba, J. Tanaka, D. Garcia Gravalos and T. Higa, J. 
Nat. Prod., 2002, 65, 1505. 
188 V. Costantino, E. Fattorusso, A. Mangoni, M. Di Rosa and A. Ianaro, J. Am. Chem. Soc., 
1997, 119, 12465. 
189 K. Mori, T. Tashiro, K. Akasaka, H. Ohrui and E. Fattorusso, Tetrahedron Lett., 2002, 43, 
3719. 
190 T. Tashiro, K. Akasaka, H. Ohrui, E. Fattorusso and K. Mori, Eur. J. Org. Chem., 2002,  
3659. 
191 M. Seki and K. Mori, Eur. J. Org. Chem., 2001, 3797. 
192 K. C. Nicolaou, J. Li and G. Zenke, Helv. Chim. Acta, 2000, 83, 1977. 
193 M. Meyer and M. Guyot, Lipids, 2002, 37, 1109. 
194 Y. Liu, C. O. Lee, J. Hong and J. H. Jung, Bull. Korean Chem. Soc., 2002, 23, 1467. 
195 V. Costantino, E. Fattorusso, C. Imperatore and A. Mangoni, J. Nat. Prod., 2002, 65, 883. 
196 V. Costantino, E. Fattorusso and A. Mangoni, J. Org. Chem., 1993, 58, 186. 
197 R. G. Linington, M. Robertson, A. Gauthier, B. B. Finlay, R. van Soest and R. J. Andersen, 
Org. Lett., 2002, 4, 4089. 
198 S. Aoki, K. Matsui, H. Wei, N. Murakami and M. Kobayashi, Tetrahedron, 2002, 58, 5417. 
 58 
199 K. Watanabe, Y. Tsuda, Y. Yamane, H. Takahashi, K. Iguchi, H. Naoki, T. Fujita and R. W. 
M. van Soest, Tetrahedron Lett., 2000, 41, 9271. 
200 J. S. Yadav and R. K. Mishra, Tetrahedron Lett., 2002, 43, 1739. 
201 Y. Nakao, T. Uehara, S. Matsunaga, N. Fusetani and R. W. M. van Soest, J. Nat. Prod., 2002, 
65, 922. 
202 H. Li, S. Matsunaga and N. Fusetani, J. Nat. Prod., 1994, 57, 1464. 
203 S. Nishimura, S. Matsunaga, M. Shibazaki, K. Suzuki, N. Harada, H. Naoki and N. Fusetani, 
J. Nat. Prod., 2002, 65, 1353. 
204 T. N. Makarieva, E. A. Santalova, I. A. Gorshkova, A. S. Dmitrenok, A. G. Guzii, V. I. 
Gorbach, V. I. Svestashev and V. A. Stonik, Lipids, 2002, 37, 75. 
205 J. S. Mynderse and R. E. Moore, Phytochemistry, 1979, 18, 1181. 
206 M. R. Rao and D. J. Faulkner, J. Nat. Prod., 2002, 65, 1201. 
207 J. S. Sandler, P. L. Colin, J. N. A. Hooper and D. J. Faulkner, J. Nat. Prod., 2002, 65, 1258. 
208 A. Qureshi, J. Salvá, M. K. Harper and D. J. Faulkner, J. Nat. Prod., 1998, 61, 1539. 
209 M. Jung, J. Ham and J. Song, Org. Lett., 2002, 4, 2763. 
210 Y. Chen, P. J. McCarthy, D. K. Harmody, R. Schimoler-O'Rourke, K. Chilson, C. 
Selitrennikoff, S. A. Pomponi and A. E. Wright, J. Nat. Prod., 2002, 65, 1509. 
211 S. P. Gunasekera, M. Gunasekera, G. P. Gunawardana, P. McCarthy and N. Burres, J. Nat. 
Prod., 1990, 53, 669. 
212 G. Yao and K. Steliou, Org. Lett., 2002, 4, 485. 
213 C. Campagnuolo, E. Fattorusso, O. Taglialatela-Scafati, A. Ianaro and B. Pisano, Eur. J. Org. 
Chem., 2002, 61. 
214 A. D. Patil, A. J. Freyer, M. F. Bean, B. K. Carte, J. W. Westley, R. K. Johnson and P. 
Lahouratate, Tetrahedron, 1996, 52, 377. 
215 P. Y. Hayes and W. Kitching, J. Am. Chem. Soc., 2002, 124, 9718. 
216 J.-F. Hu, H.-F. Gao, M. Kelly and M. T. Hamann, Tetrahedron, 2002, 58, 1233. 
 59 
217 E. Fattorusso, O. Taglialatela-Scafati, M. Di Rosa and A. Ianaro, Tetrahedron, 2000, 56, 
7959. 
218 S. Sirirath, J. Tanaka, I. I. Ohtani, T. Ichiba, R. Rachmat, K. Ueda, T. Usui, H. Osada and T. 
Higa, J. Nat. Prod., 2002, 65, 1820. 
219 A. Kijjoa, R. Watanadilok, P. Sonchaeng, P. Sawangwong, M. Pedro, M. S. J. Nascimento, A. 
M. S. Silva, G. Eaton and W. Herz, Z. Naturforsch. C Biosci., 2002, 57, 732. 
220 T. Teruya, S. Nakagawa, T. Koyama, K. Suenaga and D. Uemura, Chem. Lett., 2002, 38. 
221 T. S. Bugni, G. P. Concepción, G. C. Mangalindan, M. K. Harper, R. D. James and C. M. 
Ireland, Phytochemistry, 2002, 60, 361. 
222 S. P. Gunasekera, G. K. Paul, R. E. Longley, R. A. Isbrucker and S. A. Pomponi, J. Nat. 
Prod., 2002, 65, 1643. 
223 R. A. Edrada, R. Ebel, A. Supriyono, V. Wray, P. Schupp, K. Steube, R. van Soest and P. 
Proksch, J. Nat. Prod., 2002, 65, 1168. 
224 S. Kehraus, G. M. König and A. D. Wright, J. Nat. Prod., 2002, 65, 1056. 
225 T. Wakimoto, S. Matsunaga, A. Takai and N. Fusetani, Chem. Biol., 2002, 9, 309. 
226 A. Groweiss, J. J. Newcomer, B. R. O'Keefe, A. Blackman and M. R. Boyd, J. Nat. Prod., 
1999, 62, 1691. 
227 R. K. Boeckman Jr., T. J. Clark and B. C. Shook, Org. Lett., 2002, 4, 2109. 
228 R. K. Boeckman Jr., T. J. Clark and B. C. Shook, Helv. Chim. Acta, 2002, 85, 4532. 
229 G. K. Paul, S. P. Gunasekera, R. E. Longley and S. A. Pomponi, J. Nat. Prod., 2002, 65, 59. 
230 A. R. Carroll, G. K. Pierens, G. Fechner, P. de Almeida Leone, A. Ngo, M. Simpson, E. 
Hyde, J. N. A. Hooper, S.-L. Boström, D. Musil and R. J. Quinn, J. Am. Chem. Soc., 2002, 
124, 13340. 
231 S. Hanessian, R. Margarita, A. Hall, S. Johnstone, M. Tremblay and L. Parlanti, J. Am. Chem. 
Soc., 2002, 124, 13342. 
 60 
232 L. Ciasullo, A. Casapullo, A. Cutignano, G. Bifulco, C. Debitus, J. Hooper, L. Gomez-Paloma 
and R. Riccio, J. Nat. Prod., 2002, 65, 407. 
233 H. Itokawa, K. Watanabe, S. Kawaoto and T. Inoue, Jpn. Kokai Tokkyo Koho, Pat. no. JP 
63203671, 1988. 
234 S. Kehraus, G. M. König, A. D. Wright and G. Woerheide, J. Org. Chem., 2002, 67, 4989. 
235 Y. Nakao, N. Oku, S. Matsunaga and N. Fusetani, J. Nat. Prod., 1998, 61, 667. 
236 H. H. Wasserman and R. Zhang, Tetrahedron Lett., 2002, 43, 3743. 
237 H. H. Wasserman and R. Zhang, Tetrahedron, 2002, 58, 6277. 
238 Y. Murakami, M. Takei, K. Shindo, C. Kitazume, J. Tanaka, T. Higa and H. Fukamachi, J. 
Nat. Prod., 2002, 65, 259. 
239 S. Deng and J. Taunton, J. Am. Chem. Soc., 2002, 124, 916. 
240 F. Yokokawa, H. Sameshima, Y. In, K. Minoura, T. Ishida and T. Shioiri, Tetrahedron, 2002, 
58, 8127. 
241 L. T. Tan, R. T. Williamson, W. H. Gerwick, K. S. Watts, K. McGough and R. Jacobs, J. 
Org. Chem., 2000, 65, 419. 
242 J. N. Tabudravu, M. Jaspars, L. A. Morris, J. J. Kettenes-van den Bosch and N. Smith, J. Org. 
Chem., 2002, 67, 8593. 
243 G. R. Pettit, R. Tan, M. D. Williams, L. Tackett, J. M. Schmidt, R. L. Cerny and J. N. A. 
Hooper, Bioorg. Med. Chem. Lett., 1993, 3, 2869. 
244 J. N. Tabudravu, L. A. Morris, J. J. Kettenes-van den Bosch and M. Jaspars, Tetrahedron, 
2002, 58, 7863. 
245 A. Randazzo, G. Bifulco, C. Giannini, M. Bucci, C. Debitus, G. Cirino and L. Gomez-
Paloma, J. Am. Chem. Soc., 2001, 123, 10870. 
246 C. Della Monica, A. Randazzo, G. Bifulco, P. Cimino, M. Aquino, I. Izzo, F. De Riccardis 
and L. Gomez-Paloma, Tetrahedron Lett., 2002, 43, 5707. 
247 Y. Sera, K. Adachi, K. Fujii and Y. Shizuri, Mar. Biotechnol., 2002, 3, 441. 
 61 
248 R. J. Capon, J. Ford, E. Lacey, J. H. Gill, K. Heiland and T. Friedel, J. Nat. Prod., 2002, 65, 
358. 
249 A. Zampella, A. Randazzo, N. Borbone, S. Luciani, L. Trevisi, C. Debitus and M. V. D'Auria, 
Tetrahedron Lett., 2002, 43, 6163. 
250 A. Zampella, M. V. D'Auria, L. G. Paloma, A. Casapullo, L. Minale, C. Debitus and Y. 
Henin, J. Am. Chem. Soc., 1996, 118, 6202. 
251 Y. Okada, S. Matsunaga, R. W. M. van Soest and N. Fusetani, Org. Lett., 2002, 4, 3039. 
252 A. Zampella, M. V. D'Auria, L. Minale, C. Debitus, C. Roussakis, J. Am. Chem. Soc., 1996, 
118, 11085. 
253 B. M. Trost, O. Dirat and J. L. Gunzner, Angew. Chem. Int. Ed. Eng., 2002, 41, 841. 
254 D. A. Evans, E. Hu, J. D. Burch and G. Jaeschke, J. Am. Chem. Soc., 2002, 124, 5654. 
255 B. M. Trost, J. L. Gunzner, O. Dirat and Y. H. Rhee, J. Am. Chem. Soc., 2002, 124, 10396. 
256 P. A. Horton, F. E. Koehn, R. E. Longley and O. J. McConnell, J. Am. Chem. Soc., 1994, 116, 
6015. 
257 E. Lee, H. Y. Song, J. W. Kang, D.-S. Kim, C.-K. Jung and J. M. Joo, J. Am. Chem. Soc., 
2002, 124, 384. 
258 E. Lee, H. Y. Song, J. M. Joo, J. W. Kang, D.-S. Kim, C.-K. Jung, C. Y. Hong, S. W. Yeong 
and K. Jeon, Bioorg. Med. Chem., 2002, 12, 3519. 
259 A. Cutignano, I. Bruno, G. Bifulco, A. Casapullo, C. Debitus, L. Gomez-Paloma and R. 
Riccio, Eur, J. Org. Chem., 2001, 775. 
260 A. B. Smith III and I. G. Safonov, Org. Lett., 2002, 4, 635. 
261 A. B. Smith III, I. G. Safonov and R. M. Corbett, J. Am. Chem. Soc., 2002, 124, 11102. 
262 J. Tanaka and T. Higa, Tetrahedron Lett., 1996, 37, 5535. 
263 M. R. Rao and D. J. Faulkner, J. Nat. Prod., 2002, 65, 386. 
264 K. L. Erickson, K. R. Gustafson, L. K. Pannell, J. A. Beutler and M. R. Boyd, J. Nat. Prod., 
2002, 65, 1303. 
 62 
265 P. Phuwapraisirisan, S. Matsunaga, R. W. M. van Soest and N. Fusetani, J. Nat. Prod., 2002, 
65, 942. 
266 M. A. Rashid, C. L. Cantrell, K. R. Gustafson and M. R. Boyd, J. Nat. Prod., 2001, 64, 1341. 
267 M. A. Rashid, K. R. Gustafson, R. C. Crouch, A. Groweiss, L. K. Pannell, Q. N. Van and M. 
R. Boyd, Org. Lett., 2002, 4, 3293. 
268 N. K. Utkina, V. A. Denisenko, M. V. Virovaya, O. V. Scholokova and N. G. Prokof'eva, J. 
Nat. Prod., 2002, 65, 1213. 
269 M. Kuramoto, T. Fujita and N. Ono, Chem. Lett., 2002, 464. 
270 D. E. Williams, P. Lassota and R. J. Andersen, J. Org. Chem., 1998, 63, 4838. 
271 D. E. Williams, K. S. Craig, B. Patrick, L. M. McHardy, R. van Soest, M. Roberge and R. J. 
Andersen, J. Org. Chem., 2002, 67, 245. 
272 D. B. Stierle, D. J. Faulkner, J. Nat. Prod., 1991, 54, 1134. 
273 R. C. Larock and Y. Wang, Tetrahedron Lett., 2002, 43, 21. 
274 S. Tsukamoto, M. Takahashi, S. Matsunaga, N. Fusetani and R. W. M. van Soest, J. Nat. 
Prod., 2000, 63, 682. 
275 W. R. F. Goundry, V. Lee and J. E. Baldwin, Tetrahedron Lett., 2002, 43, 2745. 
276 M. Tsuda, K. Hirano, T. Kubota and J. Kobayashi, Tetrahedron Lett., 1999, 40, 4819. 
277 J. E. Baldwin, S. P. Romeril, V. Lee and T. D. W. Claridge, Org. Lett., 2001, 3, 1145. 
278 B. B. Snider and B. Shi, Tetrahedron Lett., 2001, 42, 1639. 
279 S. P. Romeril, V. Lee, T. D. W. Claridge and J. E. Baldwin, Tetrahedron Lett., 2002, 43, 327. 
280 L. Chill, T. Yosief and Y. Kashman, J. Nat. Prod., 2002, 65, 1738. 
281 K. Y. Orabi, K. A. El Sayed, M. T. Hamann, D. C. Dunbar, M. S. Al-Said, T. Higa and M. 
Kelly, J. Nat. Prod., 2002, 65, 1782. 
282 M. Nakagawa, M. Endo, N. Tanaka and L. Gen-Pei, Tetrahedron Lett., 1984, 25, 3227. 
283 S.-S. Moon, J. B. MacMillan, M. M. Olmstead, T. A. Ta, I. N. Pessah and T. F. Molinski, J. 
Nat. Prod., 2002, 65, 249. 
 63 
284 M. Yousaf, K. A. El Sayed, K. V. Rao, C. W. Lim. J.-F. Hu, M. Kelly, S. G. Franzblau, F. 
Zhang, O. Peraud, R. T. Hill and M. T. Hamann, Tetrahedron, 2002, 58, 7397. 
285 J. M. Humphrey, Y. Liao, A. Ali, T. Rein, Y.-L. Wong, H.-J. Chen, A. K. Courtney and S. F. 
Martin, J. Am. Chem. Soc., 2002, 124, 8584. 
286 R. J. Capon, C. Skene, D. Vuong, E. Lacey, J. H. Gill, K. Heiland and T. Friedel, J. Nat. 
Prod., 2002, 65, 368. 
287 A. D. Patil, A. J. Freyer, B. Carte, P. B. Taylor, R. K. Johnson and D. J. Faulkner, J. Nat. 
Prod., 2002, 65, 628. 
288 J.-F. Hu, J. A. Schetz, M. Kelly, J.-N. Peng, K. K. H. Ang, H. Flotow, C. Y. Leong, S. B. Ng, 
A. D. Buss, S. P. Wilkins and M. T. Hamann, J. Nat. Prod., 2002, 65, 476. 
289 S. Sölter, R. Dieckmann, M. Blumenberg and W. Francke, Tetrahedron Lett., 2002, 43, 3385. 
290 G. Lidgren, L. Bohlin and J. Bergmann, Tetrahedron Lett., 1986, 27, 3283. 
291 A. Lieberknecht and H. Griesser, Tetrahedron Lett., 1987, 28, 4275. 
292 M. J. McKay, A. R. Carroll, R. J. Quinn and J. N. A. Hooper, J. Nat. Prod., 2002, 65, 595. 
293 M. Salmoun, C. Devijver, D. Daloze, J.-C. Braekman and R. W. M. van Soest, J. Nat. Prod., 
2002, 65, 1173. 
294 S. P. Gunasekera, P. J. McCarthy and M. Kelly-Borges, J. Nat. Prod., 1994, 57, 14537. 
295 B. Jiang, C.-G. Yang and J. Wang, J. Org. Chem., 2002, 67, 1396. 
296 A. Casapullo, G. Bifulco, I. Bruno and R. Riccio, J. Nat. Prod., 2000, 63, 447. 
297 F. Y. Miyake, K. Yakushijin and D. A. Horne, Org. Lett., 2002, 4, 941. 
298 T. Kawasaki, K. Ohno, H. Enoki, Y. Umemoto and M. Sakamoto, Tetrahedron Lett., 2002, 
43, 4245. 
299 A. E. Wright, S. A. Pomponi, S. S. Cross and P. McCarthy, J. Org. Chem., 1992, 57, 4772. 
300 R. J. Capon, F. Rooney, L. M. Murray, E. Collins, A. T. R. Sim, J. A. P. Rostas, M. S. Butler 
and A. R. Carroll, J. Nat. Prod., 1998, 61, 660. 
301 N. K. Garg, R. Sarpong and B. M. Stoltz, J. Am. Chem. Soc., 2002, 124, 13179. 
 64 
302 K. M. Meragelman, L. M. West, P. T. Northcote, L. K. Pannell, T. C. McKee and M. R. 
Boyd, J. Org. Chem., 2002, 67, 6671. 
303 L. C. Chang, S. Otero-Quintero, J. N. A. Hooper and C. A. Bewley, J. Nat. Prod., 2002, 65, 
776. 
304 N. B. Perry, J. W. Blunt and M. H. G. Munro, Tetrahedron, 1988, 44, 1727. 
305 H. Tohma, Y. Harayama, M. Hashizume, M. Iwata, M. Egi and Y. Kita, Angew. Chem. Int. 
Ed. Eng., 2002, 41, 348. 
306 R. D. Charan, T. C. McKee, K. R. Gustafson, L. K. Pannell and M. R. Boyd, Tetrahedron 
Lett., 2002, 43, 5201. 
307 Z. Thale, T. Johnson, K. Tenney, P. J. Wenzel, E. Lobkovsky, J. Clardy, J. Media, H. 
Pietraszkiewicz, F. A. Valeriote and P. Crews, J. Org. Chem., 2002, 67, 9384. 
308 M. Tsuda, H. Uemoto and J. Kobayashi, Tetrahedron Lett., 1999, 40, 5709. 
309 M. K. Gurjar and S. Bera, Org. Lett., 2002, 4, 3569. 
310 B. Jiang, J.-F. Liu and S.-Y. Zhao, Org. Lett., 2002, 4, 3951. 
311 G. R. Pettit, J. McNulty, D. L. Herald, D. L. Doubek, J. C. Chapuis, J. M. Schmidt, L. P. 
Tackett and M. R. Boyd, J. Nat. Prod., 1997, 60, 180. 
312 S. A. Fedoreyev, N. K. Utkina, S. G. Ilyin, M. V. Reshetnyak and O. B. Maximov, 
Tetrahedron Lett., 1986, 27, 3177. 
313 K. J. Wiese, K. Yakushijin and D. A. Horne, Tetrahedron Lett., 2002, 43, 5135. 
314 M. Assmann and M. Köck, Z. Naturforsch. C Biosci., 2002, 57, 153. 
315 G. Groszek, D. Kantoci and G. R. Pettit, Liebigs Ann. Chem., 1995, 715. 
316 A. D. Patil, A. J. Freyer, L. Killmer, G. Hofmann and R. K. Johnson, Nat. Prod. Lett., 1997, 
9, 201. 
317 K. Inaba, H. Sato, M. Tsuda and J. Kobayashi, J. Nat. Prod., 1998, 61, 693. 
318 A. C. B. Sosa, K. Yakushijin and D. A. Horne, J. Org. Chem., 2002, 67, 4498. 
 65 
319 M. D'Ambrosio, A. Guerriero, C. Debitus, O. Ribes, J. Pusset, S. Leroy and F. Pietra, J. 
Chem. Soc. Chem. Commun., 1993, 1305. 
320 K. S. Feldman and J. C. Saunders, J. Am. Chem. Soc., 2002, 124, 9060. 
321 K. S. Feldman, J. C. Saunders and M. L. Wrobleski, J. Org. Chem., 2002, 67, 7096. 
322 X. Fu, J. R. Barnes, T. Do and F. J. Schmitz, J. Nat. Prod., 1997, 60, 497. 
323 R. K. Akee, T. R. Carroll, W. Y. Yoshida, P. J. Scheuer, T. J. Stout and J. Clardy, J. Org. 
Chem., 1990, 55, 1944. 
324 S. Nakamura, I. Kawasaki, M. Kunimura, M. Matsui, Y. Noma, M. Yamashita and S. Ohta, J. 
Chem. Soc. Perkin Trans. 1, 2002, 1061. 
325 H. Gross, S. Kehraus, G. M. König, G. Woerheide and A. D. Wright, J. Nat. Prod., 2002, 65, 
1190. 
326 M. Assmann and M. Köck, Z. Naturforsch. C Biosci., 2002, 57, 157. 
327 J. C. Braekman, D. Daloze, R. Travares, E. Hajdu and R. W. M. Van Soest, J. Nat. Prod., 
2000, 63, 193. 
328 K. Nagasawa, A. Georgieva, H. Koshino, T. Nakata, T. Kita and Y. Hashimoto, Org. Lett., 
2002, 4, 177. 
329 M. Tsuda, T. Endo, K. Watanabe, J. Fromont and J. Kobayashi, J. Nat. Prod., 2002, 65, 1670. 
330 J. N. Tabudravu, V. G. H. Eijsink, G. W. Gooday, M. Jaspars, D. Komander, M. Legg, B. 
Synstad and D. M. F. van Aalten, Bioorg. Med. Chem., 2002, 10, 1123. 
331 E. Quiñoá and P. Crews, Tetrahedron Lett., 1987, 28, 3229. 
332 J. N. Tabudravu and M. Jaspars, J. Nat. Prod., 2002, 65, 1798. 
333 B. M. Saeki, A. C. Granato, R. G. S. Berlinck, A. Magalhães, A. B. Schefer, A. G. Ferreira, 
U. S. Pinheiro and E. Hajdu, J. Nat. Prod., 2002, 65, 796. 
334 J. C. Coll, P. S. Kearns, J. A. Rideout and V. Sankar, J. Nat. Prod., 2002, 65, 753. 
335 I. A. Zuleta, M. L. Vitelli, R. Baggio, M. T. Garland, A. M. Seldes and J. A. Palermo, 
Tetrahedron, 2002, 58, 4481. 
 66 
336 S. Hirsch, A. Rudi, Y. Kashman and Y. Loya, J. Nat. Prod., 1991, 54, 92. 
337 K. A. Alvi, M. C. Diaz, P. Crews, D. L. Slate, R. H. Lee and R. Moretti, J. Org. Chem., 1992, 
57, 6604. 
338 K. Igushi, A. Sahashi, J. Kohno and Y. Yamada, Chem. Pharm. Bull., 1990, 38, 1121. 
339 T. Ling, E. Poupon, E. J. Rueden, S. H. Kim and E. A. Theodorakis, J. Am. Chem. Soc., 2002, 
124, 12261. 
340 P. Djura, D. B. Stierle, B. Sullivan, D. J. Faulkner, E. Arnold and J. Clardy, J. Org. Chem., 
1980, 45, 1435. 
341 M. Nakamura, A. Suzuki, M. Nakatani, T. Fuchikami, M. Inoue and T. Katoh, Tetrahedron 
Lett., 2002, 43, 6929. 
342 H. Mitome, T. Nagasawa, H. Miyaoka, Y. Yamada and R. W. M van Soest, Tetrahedron, 
2002, 58, 1693. 
343 H. R. Bokesch, A. C. Stull, L. K. Pannell, T. C. McKee and M. R. Boyd, Tetrahedron Lett., 
2002, 43, 3079. 
344 M. Iwashima, I. Terada, K. Iguchi and T. Yamori, Chem. Pharm. Bull., 2002, 50, 1286. 
345 M. M. Uy, S. Ohta, M. Yanai, E. Ohta, T. Hirata and S. Ikegami, Bioorg. Med. Chem. Lett., 
2002, 12, 3037. 
346 J. Peng, S. G. Franzblau, F. Zhang and M. T. Hamann, Tetrahedron Lett., 2002, 43, 9699. 
347 N. V. Petrichtcheva, C. Duque, A. Dueñas, S. Zea, N. Hara and Y. Fujimoto, J. Nat. Prod., 
2002, 65, 851. 
348 C. J. Barrow, J. W. Blunt and M. H. G. Munro, Aust. J. Chem., 1988, 41, 1755. 
349 K. Oesterreich, I. Klein and D. Spitzner, Synlett., 2002, 10, 1712. 
350 T. Okino, E. Yoshimura, H. Hirota and N. Fusetani, Tetrahedron Lett., 1995, 36, 8637. 
351 H. Miyaoka, H. Shida, N. Yamada, H. Mitome and Y. Yamada, Tetrahedron Lett., 2002, 43, 
2227. 
352 J.-R. Rho, H.-S. Lee and C. J. Sim and J. Shin, Tetrahedron, 2002, 58, 9585. 
 67 
353 J. Peng, K. Walsh, V. Weedman, J. D. Bergthold, J. Lynch, K. L. Lieu, I. A. Braude, M. Kelly 
and M. T. Hamann, Tetrahedron, 2002, 58, 7809. 
354 L. Ciasullo, A. Cutignano, A. Casapullo, R. Puliti, C. A. Mattia, C. Debitus, R. Riccio and L. 
Gomez-Paloma, J. Nat. Prod., 2002, 65, 1210. 
355 Y. Liu, J. Hong, C.-O. Lee, K. S. Im, N. D. Kim, J. S. Choi and J. H. Jung, J. Nat. Prod., 
2002, 65, 1307. 
356 Y. Liu, B. H. Bae, N. Alam, J. Hong, C. J. Sim, C. Lee, K. S. Im and J. H. Jung, J. Nat. Prod., 
2001, 64, 1301. 
357 K. S. Craig, D. E. Williams, I. Hollander, E. Frommer, R. Mallon, K. Collins, D. 
Wojciechowicz, A. Tahir, R. van Soest and R. J. Andersen, Tetrahedron Lett., 2002, 43, 4801. 
358 M. Tsuda, T. Endo, Y. Mikami, J. Fromont and J. Kobayashi, J. Nat. Prod., 2002, 65, 1507. 
359 R. D. Charan, T. C. McKee and M. R. Boyd, J. Nat. Prod., 2002, 65, 492. 
360 S. de Rosa, A. Crispino, A. de Giulio and C. Iodice, J. Nat. Prod., 1995, 58, 1776. 
361 A. K. Cheung and M. L. Snapper, J. Am. Chem. Soc., 2002, 124, 11584. 
362 D. T. A. Youssef, R. K. Yamaki, M. Kelly and P. J. Scheuer, J. Nat. Prod., 2002, 65, 2. 
363 M. C. Roy, J. Tanaka, N. de Voogd and T. Higa, J. Nat. Prod., 2002, 65, 1838. 
364 C. C. Stessman, R. Ebel, A. J. Corvino and P. Crews, J. Nat. Prod., 2002, 65, 1183. 
365 J.-F. Hu, M. Kelly and M. T. Hamann, Steroids, 2002, 67, 743. 
366 G. Santafé, V. Paz, J. Rodríguez and C. Jiménez, J. Nat. Prod., 2002, 65, 1161. 
367 L. Yang and R. J. Andersen, J. Nat. Prod., 2002, 65, 1924. 
368 R. A. Keyzers, P. T. Northcote and V. Webb, J. Nat. Prod., 2002, 65, 598. 
369 T. Miyamoto, K. Kodama, Y. Aramaki, R. Higuchi and R. W. M. Van Soest, Tetrahedron 
Lett., 2001, 42, 6349. 
370 B. Liu and W. Zhou, Tetrahedron Lett., 2002, 43, 4187. 
371 S. Aoki, Y. Naka, T. Itoh, T. Furukawa, R. Rachmat, S. Akiyama and M. Kobayashi, Chem. 
Pharm. Bull., 2002, 50, 827. 
 68 
372 N. Borbone, S. De Marino, M. Iorizzi, F. Zollo, C. Debitus, G. Esposito and T. Iuvone, J. Nat. 
Prod., 2002, 65, 1206. 
373 A. I. Kalinovsky, A. S. Antonov, S. S. Afiyatullov, P. S. Dimitrenok, E. V. Evtuschenko and 
V. A. Stonik, Tetrahedron Lett., 2002, 43, 523. 
374 J. L. McCormick, T. C. McKee, J. H. Cardellina II, M. Leid and M. R. Boyd, J. Nat. Prod., 
1996, 59, 1047. 
375 D. Tasdemir, G. C. Mangalindan, G. P. Concepción, S. M. Verbitski, S. Rabindran, M. 
Miranda, M. Greenstein, J. N. Hooper, M. K. Harper and C. M Ireland, J. Nat. Prod., 2002, 
65, 210. 
376 D. E. Williams, A. Tahir and R. J. Andersen, J. Nat. Prod., 1999, 62, 653. 
377 D. Enders and T. Schüßeler, Synthesis, 2002, 2280. 
378 M. L. Ciavatta, G. Scognamiglio, E. Trivellone, T. Bisogno and G. Cimino, Tetrahedron, 
2002, 58, 4943. 
379 K. Takada, Y. Nakao, S. Matsunaga, R. W. M. van Soest and N. Fusetani, J. Nat. Prod., 2002, 
65, 411. 
380 M. Vanisree and G. V. Subbaraju, Asian J. Chem., 2002, 14, 957. 
381 R. Parvataneni and P. V. S. Rao, J. Indian Chem. Soc., 2002, 79, 732. 
382 X.-X. He, R.-L. Yang, J.-Y. Su and L.-M. Zeng, Zhongshan Daxue Xuebao, Ziran Kexueban, 
2002, 41, 114. 
383 P. S. Parameswaran, C. G. Naik, M. Govenkar and V. R. Hegde, Indian J. Chem. Sect. B, 
2002, 41, 1093. 
384 C.-Y. Duh, S.-C. Chien, P.-Y. Song, S.-K. Wang, A. A. H. El-Gamal and C.-F. Dai, J. Nat. 
Prod., 2002, 65, 1853. 
385 J. A. Palermo, M. F. Rodríguez Brasco, C. Spagnuolo and A. M. Seldes, J. Org. Chem., 2000, 
65, 4482. 
386 B. Witulski, A. Zimmermann and N. D. Gowans, Chem. Commun., 2002, 2984. 
 69 
387 G.-H. Wang, A. F. Ahmed, Y.-H. Kuo and J.-H. Sheu, J. Nat. Prod., 2002, 65, 1033. 
388 J.-Y. Su, Y.-L. Zhong and L.-M. Zeng, J. Nat. Prod., 1993, 56, 288. 
389 F. Coelho and G. Diaz, Tetrahedron, 2002, 58, 1647. 
390 G.-H. Wang, A. F. Ahmed, J.-H. Sheu, C.-Y. Duh, Y.-C. Shen and L.-T. Wang, J. Nat. Prod., 
2002, 65, 887. 
391 A. Rudi, S. Levi, Y. Benayahu and Y. Kashman, J. Nat. Prod., 2002, 65, 1672. 
392 N. S. Reddy, T. V. Goud and Y. Venkateswarlu, J. Nat. Prod., 2002, 65, 1059. 
393 A. D. Rodríguez and I. I. Rodríguez, Tetrahedron Lett., 2002, 43, 5601. 
394 A. D. Rodríguez, E. González and S. D. Huang, J. Org. Chem., 1998, 63, 7083. 
395 H. Miyaoka, D. Honda, H. Mitome and Y. Yamada, Tetrahedron Lett., 2002, 43, 7773. 
396 C.-Y. Duh, A. A. H. El-Gamal, C.-J. Chu, S.-K. Wang and C.-F. Dai, J. Nat. Prod., 2002, 65, 
1535. 
397 M. Iwashima, I. Terada, K. Okamoto and K. Iguchi, J. Org. Chem., 2002, 67, 2977. 
398 C.-Y. Duh, A. A. H. El-Gamal, S.-K. Wang and C.-F. Dai, J. Nat. Prod., 2002, 65, 1429. 
399 K. Mori, K. Iguchi, N. Yamada, Y. Yamada and Y. Inouye, Chem. Pharm. Bull., 1988, 36, 
2840. 
400 K. Iguchi, H. Sawai, H. Nishimura, M. Fujita and T. Yamori, Bull. Chem. Soc. Jpn., 2002, 75, 
131. 
401 H. Miyaoka, Y. Isaji, Y. Kajiwara, Y. Kunimune and Y. Yamada, Tetrahedron Lett., 1998, 
39, 6503. 
402 M. Iwashima, Y. Matsumoto, Y. Takenaka, K. Iguchi and T. Yamori, J. Nat. Prod., 2002, 65, 
1441. 
403 Y. Uchio, S. Eguchi, M. Nakayama and T. Hase, Chem. Lett., 1982, 277. 
404 Y.-P. Shi, A. D. Rodríguez, C. L. Barnes, J. A. Sánchez, R. G. Raptis and P. Baran, J. Nat. 
Prod., 2002, 65, 1232. 
405 A. D. Rodríguez and H. Dhasmana, J. Nat. Prod., 1993, 56, 564. 
 70 
406 A. D. Rodríguez, I. C. Piña, J. J. Soto, D. R. Rojas and C. L. Barnes, Can. J. Chem., 1995, 73, 
643. 
407 A. D. Rodríguez and A. L. Acosta, J. Nat. Prod., 1998, 61, 40. 
408 A. Longeon, M.-L. Bourguet-Kondracki and M. Guyot, Tetrahedron Lett., 2002, 43, 5937. 
409 N. B. Pham, M. S. Butler and R. J. Quinn, J. Nat. Prod., 2002, 65, 1147. 
410 J.-H. Sheu, A. F. Ahmed, R.-T. Shiue, C.-F. Dai and Y.-H. Kuo, J. Nat. Prod., 2002, 65, 
1904. 
411 C.-W. Lin, J.-Y. Su and L.-M. Zeng, Chem. Res. Chin. Univ., 2002, 18, 189. 
412 J. H. Kwak, F. J. Schmitz and G. C. Williams, J. Nat. Prod., 2002, 65, 704. 
413 O. Taglialatela-Scafati, U. Deo-Jangra, M. Campbell, M. Roberge and R. J. Andersen, Org. 
Lett., 2002, 4, 4085. 
414 D. Banjoo, B. S. Mootoo, R. S. Ramsewak, R. Sharma, A. J. Lough, S. McLean and W. F. 
Reynolds, J. Nat. Prod., 2002, 65, 314. 
415 Y.-C. Shen, Y.-C. Lin and M. Y. Chiang, J. Nat. Prod., 2002, 65, 54. 
416 D. Friedrich and L. A. Paquette, J. Nat. Prod., 2002, 65, 126. 
417 L. A. Paquette, The Chemical Record, 2001, 1, 311. 
418 V. A. Stonik, I. I. Kapustina, A. I. Kalinovsky, P. S. Dmitrenok and B. B. Grebnev, 
Tetrahedron Lett., 2002, 43, 315. 
419 G.-H. Wang, J.-H. Sheu, C.-Y. Duh and M. Y. Chiang, J. Nat. Prod., 2002, 65, 1475. 
420 P. Radhika, P. V. S. Rao, V. Anjaneyulu, R. N. Asolkar and H. Laatsch, J. Nat. Prod., 2002, 
65, 737. 
421 N. González, J. Rodríguez, R. G. Kerr and C. Jiménez, J. Org. Chem., 2002, 67, 5117. 
422 C. Anta, N. González, G. Santafé, J. Rodríguez and C. Jiménez, J. Nat. Prod., 2002, 65, 766. 
423 C.-Y. Duh, A. A. H. El-Gamal, C.-Y. Chiang, C.-J. Chu, S.-K. Wang and C.-F. Dai, J. Nat. 
Prod., 2002, 65, 1882. 
424 C. Anta, N. González, J. Rodríguez and C. Jiménez, J. Nat. Prod., 2002, 65, 1357. 
 71 
425 M. J. Ortega, E. Zubía, S. Rodríguez, J. L. Carballo and J. Salvá, Eur. J. Org. Chem., 2002, 
3250. 
426 X.-X. He, J.-Y. Su, L.-M. Zeng, X.-P. Yang and Y.-J. Liang, Huaxue Xuebao, 2002, 60, 334. 
427 Y. Tomono, H. Hirota, Y. Imahara and N. Fusetani, J. Nat. Prod., 1999, 62, 1538. 
428 M. Linker and W. Kreiser, Helv. Chim. Acta, 2002, 85, 1096. 
429 Z.-Y. Shao, D.-Y. Zhu and Y.-W. Guo, J. Nat. Prod., 2002, 65, 1675. 
430 J. Tanaka, A. Trianto, M. Musman, H. H. Issa, I. I. Ohtani, T. Ichiba, T. Higa, W. Y. Yoshida 
and P. J. Scheuer, Tetrahedron, 2002, 58, 6259. 
431 J. Tanaka, T. Higa, K. Tachibana and T. Iwashita, Chem. Lett., 1982, 1295. 
432 T. Higa, J. Tanaka and K. Tachibana, Tetrahedron Lett., 1981, 22, 2777. 
433 N. Alam, J. Hong, C.-O. Lee, J. S. Choi, K. S. Im and J. H. Jung, Chem. Pharm. Bull., 2002, 
50, 661. 
434 A. Fontana, M. L. Ciavatta and G. Cimino, J. Org. Chem., 1998, 63, 2845. 
435 I. S. Marcos, A. B. Pedrero, M. J. Sexmero, D. Diez, P. Basabe, F. A. Hernandez, H. B. 
Broughton and J. G. Urones, Synlett, 2002, 105. 
436 A. Suksamrarn, A. Jankam, B. Tarnchompoo and S. Putchakarn, J. Nat. Prod., 2002, 65, 
1194. 
437 N. Lindquist, J. Nat. Prod., 2002, 65, 681. 
438 S.-Y. Zhang, Y.-H. Yi, H.-F. Tang, Q.-Z. Xu, Z.-R. Zou and L. Li, Dier Junyi Daxue Xuebao, 
2002, 23, 250. 
439 P. Macek and D. Lebez, Toxicon, 1988, 26, 441. 
440 M. G. Hinds, W. Zhang, G. Anderluh, P. E. Hansen and R. S. Norton, J. Mol. Biol., 2002, 
315, 1219. 
441 Q. Hong, I. Gutiérrez-Aguirre, A. Barlic, P. Malovrh, K. Kristan, Z. Podlesek, P. Macek, D. 
Turk, J. M. González-Mañas, J. H. Lakey and G. Anderluh, J. Biol. Chem., 2002, 277, 41916. 
 72 
442 H. Nagai, N. Oshira, K. Takuwa-Kuroda, S. Iwanaga, M. Nozaki and T. Nakajima, Biosci. 
Biotechnol. Biochem., 2002, 66, 2621. 
443 M. M. Monastyrnaya, T. A. Zykova, O. V. Apalikova, T. V. Shwets and E. P. Kozlovskaya, 
Toxicon, 2002, 40, 1197. 
444 A. Fürstner, A. Leitner, M. Méndez and H. Krause, J. Am. Chem. Soc., 2002, 124, 13856. 
445 T. J. Speed and D. M. Thamattoor, Tetrahedron Lett., 2002, 43, 367. 
446 N. Alam, J. Hong, C. O. Lee, K. S. Im, B. W. Son, J. S. Choi, W. C. Choi, and J. H. Jung, J. 
Nat. Prod., 2001, 64, 956. 
447 B. H. Bae, K. S. Im, W. C. Choi, J. Hong, C.-O. Lee, J. S. Choi, B. W. Son, J.-I. Song and J. 
H. Jung, J. Nat. Prod., 2000, 63, 1511. 
448 M. Zhang, K. Long, H. Wu and K. Ma, J. Nat. Prod., 1994, 57, 155. 
449 W. K. Liu, N. L. Y. Wong, H. M. Huang, J. K. C. Ho, W. H. Zhang and C. T. Che, Life Sci., 
2002, 70, 843. 
450 E. P. Loret, R. M. S. del Valle, P. Mansuelle, F. Sampieri and H. Rochat, J. Biol. Chem., 
1994, 269, 16785. 
451 F. Bosmans, A. Aneiros and J. Tytgat, FEBS Lett., 2002, 532, 131. 
452 P. Wulff, J. S. Carlé and C. J. Christophersen, J. Chem. Soc. Perkin Trans. 1, 1981, 2895. 
453 L. Peters, G. M. König, H. Terlau and A. D. Wright, J. Nat. Prod., 2002, 65, 1633. 
454 N. Lysek, E. Rachor and T. Lindel, Z. Naturforsch. C Biosci., 2002, 57, 1056. 
455 J. L. C. Wright, J. Nat. Prod., 1984, 47, 893. 
456 J. S. Carlé and C. Christophersen, J. Am. Chem. Soc., 1979, 101, 4012. 
457 P. B. Holst, U. Anthoni, C. Christophersen and P. H. Nielsen, J. Nat. Prod., 1994, 57, 997. 
458 M. S. Morales-Ríos, N. F. Santos-Sánchez, O. R. Suárez-Castillo and P. Joseph-Nathan, 
Magn. Reson. Chem., 2002, 40, 677. 
459 C. K. Narkowicz, A. J. Blackman, E. Lacey, J. H. Gill and K. Heiland, J. Nat. Prod., 2002, 
65, 938. 
 73 
460 S.-J. Jeong, R. Higuchi, T. Miyamoto, M. Ono, M. Kuwano and S. F. Mawatari, J. Nat. Prod., 
2002, 65, 1344. 
461 S. Eisenbarth, M. Gehling, A. Harder and B. Steffan, Tetrahedron, 2002, 58, 8461. 
462 M. S. Morales-Ríos, O. R. Suárez-Castillo and P. Joseph-Nathan, Tetrahedron, 2002, 58, 
1479. 
463 C. C. Hughes and D. Trauner, Angew. Chem. Int. Ed. Eng., 2002, 41, 4556. 
464 B. D. Morris and M. R. Prinsep, J. Nat. Prod., 1999, 62, 688. 
465 A. J. Blackman and D. J. Matthews, Heterocycles, 1985, 23, 2829. 
466 M. Ramirez Osuna, G. Aguirre, R. Somanathan and E. Molins, Tetrahedron: Asymm., 2002, 
13, 2261. 
467 M. L. Ciavatta, E. Trivellone, G. Villani and G. Cimino, Tetrahedron Lett., 1993, 34, 6791. 
468 R. A. Sampson and M. V. Perkins, Org. Lett., 2002, 4, 1655. 
469 M. V. Perkins and R. A. Sampson, Org. Lett., 2001, 3, 123. 
470 M. A. Calter and W. Liao, J. Am. Chem. Soc., 2002, 124, 13127. 
471 M. Norte, F. Cataldo, A. G. González, M. L. Rodríguez and C. Ruiz-Perez, Tetrahedron, 
1990, 46, 1669. 
472 I. Paterson, D. Y.-K. Chen and A. S. Franklin, Org. Lett., 2002, 4, 391. 
473 J. E. Hochlowski, J. C. Coll, D. J. Faulkner, J. E. Biskupiak, C. M. Ireland, Q.-T. Zheng, C.-
H. He and J. Clardy, J. Am. Chem. Soc., 1984, 106, 6748. 
474 P. Ciminiello, C. Dell'Aversano, E. Fattorusso, M. Forino, S. Magno, M. Di Rosa, A. Ianaro 
and R. Poletti, J. Am. Chem. Soc., 2002, 124, 13114. 
475 P. Ciminiello, C. Dell'Aversano, E. Fattorusso, M. Forino, S. Magno and R. Poletti, Chem. 
Res. Toxicol., 2002, 15, 979. 
476 S. J. Fahey and M. J. Garson, J. Chem. Ecol., 2002, 28, 1773. 
477 D. R. Appleton, M. A. Sewell, M. V. Berridge and B. R. Copp, J. Nat. Prod., 2002, 65, 630. 
 74 
478 J. Kimura, Y. Takada, T. Inayoshi, Y. Nakao, G. Goetz, W. Y. Yoshida and P. J. Scheuer, J. 
Org. Chem., 2002, 67, 1760. 
479 J. Rajaganapathi, K. Kathiresan and T. P. Singh, Mar. Biotechnol., 2002, 4, 447. 
480 J. M. McIntosh, C. Dowell, M. Watkins, J. E. Garrett, D. Yoshikami and B. M. Olivera, J. 
Biol. Chem., 2002, 277, 33610. 
481 S. W. Ayer and R. J. Andersen, Experientia, 1983, 39, 255. 
482 T. Barsby, R. G. Linington and R. J. Andersen, Chemoecology, 2002, 12, 199. 
483 B. J. Burreson, P. J. Scheuer, J. Finer and J. Clardy, J. Am. Chem. Soc., 1975, 97, 4763. 
484 A. Srikrishna and P. R. Kumar, Tetrahedron Lett., 2002, 43, 1109. 
485 K. L. McPhail, M. T. Davies-Coleman, R. C. B. Copley and D. S. Eggleston, J. Nat. Prod., 
1999, 62, 1618. 
486 R. C. B. Copley, M. T. Davies-Coleman, D. R. Edmonds, D. J. Faulkner and K. L. McPhail, 
J. Nat. Prod., 2002, 65, 580. 
487 J. A. Findlay and G. Li, Can. J. Chem., 2002, 80, 1697. 
488 M. Gavagnin, N. Ungur, E. Mollo, J. Templado and G. Cimino, Eur. J. Org. Chem., 2002, 
1500. 
489 A. Spinella, E. Zubía, E. Martinez, J. Ortea and G. Cimino, J. Org. Chem., 1997, 62, 5471. 
490 A. Spinella, T. Caruso and C. Coluccini, Tetrahedron Lett., 2002, 43, 1681. 
491 T. Caruso and A. Spinella, Tetrahedron: Asymm., 2002, 13, 2071. 
492 N. K. Gulavita, E. D. da Silva, M. R. Hagadone, P. Karuso, P. J. Scheuer, G. D. van Duyne 
and J. Clardy, J. Org. Chem., 1986, 51, 5136. 
493 Y. Kitano, T. Ito, T. Suzuki, Y. Nogata, K. Shinshima, E. Yoshimura, K. Chiba, M. Tada and 
I. Sakaguchi, J. Chem. Soc. Perkin Trans. 1, 2002, 2251. 
494 H. Ishiwata, T. Nemoto, M. Ojika and K. Yamada, J. Org. Chem., 1994, 59, 4710. 
495 H. Ishiwata, H. Sone, H. Kigoshi and K. Yamada, J. Org. Chem., 1994, 59, 4712. 
496 R. Bai, D. G. Covell, C. Liu, A. K. Ghosh and E. Hamel, J. Biol. Chem., 2002, 277, 32165. 
 75 
497 M. Fujita, Y. Nakao, S. Matsunaga, T. Nishikawa and N. Fusetani, J. Nat. Prod., 2002, 65, 
1936. 
498 T. C. McKee, D. L. Galinis, L. K. Pannell, J. H. Cardellina II, J. Laasko, C. M. Ireland, L. 
Murray, R. J. Capon and M. R. Boyd, J. Org. Chem., 1998, 63, 7805. 
499 R. Shen, C. T. Lin and J. A. Porco, J. Am. Chem. Soc., 2002, 124, 5650. 
500 A. Aiello, E. Fattorusso, A. Mangoni and M. Menna, Eur. J. Org. Chem., 2002, 1047. 
501 T. Rezanka and V. M. Dembitsky, Eur. J. Org. Chem., 2002, 2400. 
502 J.-F. Biard, C. Roussakis, J.-M. Kornprobst, D. Gouiffes-Barbin, J.-F. Verbist, P. Cotelle, M. 
P. Foster, C. M. Ireland and C. Debitus, J. Nat. Prod., 1994, 57, 1336. 
503 P. Wipf, Y. Uto and S. Yoshimura, Chem. Eur. J., 2002, 8, 1670. 
504 B. C. M. Potts, D. J. Faulkner, J. A. Chan, G. C. Simolike, P. Offen, M. E. Hemling and T. A. 
Francis, J. Am. Chem. Soc., 1991, 113, 6321. 
505 J. Pika and D. J. Faulkner, Nat. Prod. Lett., 1995, 7, 291. 
506 C. E. Salomon, D. H. Williams, E. Lobkovsky, J. C. Clardy and D. J. Faulkner, Org. Lett., 
2002, 4, 1699. 
507 N. González, J. Rodríguez and C. Jiménez, J. Org. Chem., 1999, 64, 5705. 
508 H. Kiyota, D. J. Dixon, C. K. Luscombe, S. Hettstedt and S. V. Ley, Org. Lett., 2002, 4, 3223. 
509 J. A. Tincu and S. W. Taylor, J. Nat. Prod., 2002, 65, 377. 
510 A. Arrault, A. Witczak-Legrand, P. Gonzalez, N. Bontemps-Subielos and B. Banaigs, 
Tetrahedron Lett., 2002, 43, 4041. 
511 C. E. Salomon and D. J. Faulkner, J. Nat. Prod., 2002, 65, 689. 
512 W. S. Jang, K. N. Kim, Y. S. Lee, M. H. Nam and I. H. Lee, FEBS Lett., 2002, 521, 81. 
513 I.-H. Lee, C. Zhao, T. Nguyen, L. Menzel, A. J. Waring, M. A. Sherman and R. I. Lehrer, J. 
Peptide Res., 2001, 58, 445. 
514 L. P. Menzel, I. H. Lee, B. Sjostrand and R. I. Lehrer, Dev. Comp. Immunol., 2002, 26, 505. 
515 A. D. Wright, E. Goclik, G. M. König and R. Kaminsky, J. Med. Chem., 2002, 45, 3067. 
 76 
516 T. Ozawa, S. Aoyagi and C. Kibayashi, J. Org. Chem., 2001, 66, 3338. 
517 R. A. Davis, A. R. Carroll and R. J. Quinn, J. Nat. Prod., 2002, 65, 454. 
518 J. F. Biard, S. Guyot, C. Roussakis, J. F. Verbist, J. Vercauteren, J. F. Weber and K. Boukef, 
Tetrahedron Lett., 1994, 35, 2691. 
519 M. Jugé, N. Grimaud, J. F. Biard, M. P. Sauviat, M. Nabil, J. F. Verbist and J. Y. Petit, 
Toxicon, 2001, 39, 1231. 
520 P. Sun, C. Sun and S. M. Weinreb, J. Org. Chem., 2002, 67, 4337. 
521 H. Abe, S. Aoyagi and C. Kibayashi, Angew. Chem. Int. Ed., 2002, 41, 3017. 
522 R. A. Davis, W. Aalbersberg, S. Meo, R. M. da Rocha and C. M. Ireland, Tetrahedron, 2002, 
58, 3263. 
523 S. Urban, J. W. Blunt and M. H. G. Munro, J. Nat. Prod., 2002, 65, 1371. 
524 M. J. Ortega, E. Zubía, J. M. Ocaña, S. Naranjo and J. Salvá, Tetrahedron, 2000, 56, 3963. 
525 F. Bellina, C. Anselmi and R. Rossi, Tetrahedron Lett., 2002, 43, 2023. 
526 T. Janosik, A.-L. Johnson and J. Bergman, Tetrahedron, 2002, 58, 2813. 
527 H. Sato, M. Tsuda, K. Watanabe and J. Kobayashi, Tetrahedron, 1998, 54, 8687. 
528 D. R. Appleton, M. J. Page, G. Lambert, M. V. Berridge and B. R. Copp, J. Org. Chem., 
2002, 67, 5402. 
529 Y. R. Torres, T. S. Bugni, R. G. S. Berlinck, C. M. Ireland, A. Magalhães, A. G. Ferreira and 
R. M. da Rocha, J. Org. Chem., 2002, 67, 5429. 
530 D. R. Appleton, A. N. Pearce, G. Lambert, R. C. Babcock and B. R. Copp, Tetrahedron, 
2002, 58, 9779. 
531 Nilar, P. J. Sidebottom, B. K. Carté and M. S. Butler, J. Nat. Prod., 2002, 65, 1198. 
532 S. M. Verbitski, C. L. Mayne, R. A. Davis, G. P. Concepcion and C. M. Ireland, J. Org. 
Chem., 2002, 67, 7124. 
533 A. Rudi, I. Goldberg, Z. Stein, F. Frolow, Y. Benayahu, M. Schleyer and Y. Kashman, J. Org. 
Chem., 1994, 59, 999. 
 77 
534 A. Rudi, T. Evan, M. Aknin and Y. Kashman, J. Nat. Prod., 2000, 63, 832. 
535 A. T. Kreipl, C. Reid and W. Steglich, Org. Lett., 2002, 4, 3287. 
536 J. Ham and H. Kang, Bull. Korean Chem. Soc., 2002, 23, 163. 
537 P. Schupp, P. Proksch and V. Wray, J. Nat. Prod., 2002, 65, 295. 
538 N. Funato, H. Takayanagi, Y. Konda, Y. Toda, Y. Harigaya, Y. Iwai and S. Omura, 
Tetrahedron Lett., 1994, 35, 1251. 
539 P. Schupp, C. Eder, P. Proksch, V. Wray, B. Schneider, M. Herderich and V. Paul, J. Nat. 
Prod., 1999, 62, 959. 
540 K. Suwanborirux, K. Charupant, S. Amnuoypol, S. Pummangura, A. Kubo and N. Saito, J. 
Nat. Prod., 2002, 65, 935. 
541 A. Endo, A. Yanagisawa, M. Abe, S. Tohma, T. Kan and T. Fukuyama, J. Am. Chem. Soc., 
2002, 124, 6552. 
542 M. J. Uddin, S. Kokubo, K. Ueda, K. Suenaga and D. Uemura, Chem. Lett., 2002, 1028. 
543 L. Garrido, E. Zubía, M. J. Ortega and J. Salvá, J. Nat. Prod., 2002, 65, 1328. 
544 M. Yoshida, M. Murata, K. Inaba and M. Morisawa, Proc. Natl. Acad. Sci. USA, 2002, 99, 
14831. 
545 X. Fu, M. B. Hossain, D. van der Helm and F. J. Schmitz, J. Am. Chem. Soc., 1994, 116, 
12125. 
546 X. Fu, M. B. Hossain, D. van der Helm and F. J. Schmitz, J. Am. Chem. Soc., 1995, 117, 
9381. 
547 M. E. Layton, C. A. Morales and M. D. Shair, J. Am. Chem. Soc., 2002, 124, 773. 
548 S. Fukuzawa, S. Matsunaga and N. Fusetani, Tetrahedron, 1995, 51, 6707. 
549 S. Lee, T. G. LaCour, D. Lantrip and P. L. Fuchs, Org. Lett., 2002, 4, 313. 
550 S. Lee and P. L. Fuchs, Org. Lett., 2002, 4, 317. 
551 A. M. Fernandez, H.-Y. He, L. A. McDonald, P. Lassota, C. Discafani, E. F. Sorensen, M. C. 
Edler, L. R. Barrows, J. C. Clardy and C. M. Ireland, Pure Appl. Chem., 1998, 70, 2130. 
 78 
552 M. C. Edler, A. M. Fernandez, P. Lassota, C. M. Ireland and L. R. Barrows, Biochem. 
Pharmacol., 2002, 63, 707. 
553 H. Kang and W. Fenical, Tetrahedron Lett., 1996, 37, 2369. 
554 S. A. Abas, M. B. Hossain, D. van der Helm, F. J. Schmitz, M. Laney, R. Cabuslay and R. C. 
Schatzman, J. Org. Chem., 1996, 61, 2709. 
555 A. M. Popov, V. L. Novikov, O. S. Radchenko and G. B. Elyakov, Doklady Biochem. 
Biophys., 2002, 385, 213. 
556 N. Takada, M. Watanabe, K. Suenaga, K. Yamada, M. Kita, and D. Uemura, Tetrahedron 
Lett., 2001, 42, 6557. 
557 M. Kita, M. Watanabe, N. Takada, K. Suenaga, K. Yamada and D. Uemura, Tetrahedron, 
2002, 58, 6405. 
558 D. Uemura, A. Takada, K. Suenaga, K. Yamada, M. Watanabe and S. Nakagawa, Jpn. Kokai 
Tokkyo Koho, 2002, 2002241362. 
559 S. Kawatake, K. Nakamura, M. Inagaki and R. Higuchi, Chem. Pharm. Bull., 2002, 50, 1091. 
560 S. Kawatake, M. Inagaki, R. Isobe, T. Miyamoto and R. Higuchi, Chem. Pharm. Bull., 2002, 
50, 1386. 
561 M. E. Díaz de Vivar, A. M. Seldes and M. S. Maier, Lipids, 2002, 37, 597. 
562 K. Yamada, K. Sasaki, Y. Harada, R. Isobe and R. Higuchi, Chem. Pharm. Bull., 2002, 50, 
1467. 
563 Y. Murata and N. U. Sata, J. Agric. Food Chem., 2000, 48, 5557. 
564 N. U. Sata, R. Kuwahara and Y. Murata, Tetrahedron Lett., 2002, 43, 115. 
565 D. Takahashi, T. Maoka, M. Tsushima, K. Fujitani, M. Kozuka, T. Matsuno and T. Shingu, 
Chem. Pharm. Bull., 2002, 50, 1609. 
566 I. I. Kapustina, L. P. Ponomarenko, O. P. Moiseenko and V. A. Stonik, Chem. Nat. 
Compounds, 2001, 37, 515. 
 79 
567 E. V. Levina, P. V. Andriyashchenko, A. I. Kalinovsky, P. S. Dmitrenok and V. A. Stonik, 
Russ. J. Bioorg. Chem., 2002, 28, 189. 
568 E. V. Levina, P. V. Andriyashchenko, A. I. Kalinovsky, P. S. Dmitrenok, V. A. Stonik and N. 
G. Prokof'eva, Russ. Chem. Bull., 2002, 51, 535. 
569 W. Wang, F. Li, N. Alam, Y. Liu, J. Hong, C.-K. Lee, K. S. Im and J. H. Jung, J. Nat. Prod., 
2002, 65, 1649. 
570 J. Qi, M. Ojika and Y. Sakagami, Bioorg. Med. Chem., 2002, 10, 1961. 
571 H. D. Chludil, A. M. Seldes and M. S. Maier, J. Nat. Prod., 2002, 65, 153. 
572 P. Radhika, V. Anjaneyulu, P. V. S. Rao, T. N. Makarieva and A. I. Kalinovosky, Indian J. 
Chem. Sect. B, 2002, 41, 1276. 
573 H. D. Chludil, C. C. Muniain, A. M. Seldes and M. S. Maier, J. Nat. Prod., 2002, 65, 860. 
574 V. R. Hegde, T.-M. Chan, H. Pu, V. P. Gullo, M. G. Patel, P. Das, N. Wagner, P. S. 
Parameswaran and C. G. Naik, Bioorg. Med. Chem. Lett., 2002, 12, 3203. 
575 N. Asai, N. Fusetani, S. Matsunaga and J. Sasaki, Tetrahedron, 2000, 56, 9895. 
576 N. Asai, N. Fusetani and S. Matsunaga, J. Nat. Prod., 2001, 64, 1210. 
577 Y. Masuda, M. Yoshida and K. Mori, Biosci. Biotechnol. Biochem., 2002, 66, 1531. 
578 E. Peña-Cabrera and L. S. Liebeskind, J. Org. Chem., 2002, 67, 1689. 
579 D. C. Rowley, M. S. T. Hansen, D. Rhodes, C. A. Sotriffer, H. Ni, J. A. McCammon, F. D. 
Bushman and W. Fenical, Bioorg. Med. Chem., 2002, 10, 3619. 
